<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth - Lui, K - 2018 | Cochrane Library</title> <meta content="Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth - Lui, K - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010239.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth - Lui, K - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010239.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010239.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth" name="citation_title"/> <meta content="Kei Lui" name="citation_author"/> <meta content="k.lui@unsw.edu.au" name="citation_author_email"/> <meta content="Lisa J Jones" name="citation_author"/> <meta content="Jann P Foster" name="citation_author"/> <meta content="Peter G Davis" name="citation_author"/> <meta content="See Kwee Ching" name="citation_author"/> <meta content="Hospital Sungai Buloh" name="citation_author_institution"/> <meta content="Ju Lee Oei" name="citation_author"/> <meta content="Royal Hospital for Women" name="citation_author_institution"/> <meta content="David A Osborn" name="citation_author"/> <meta content="University of Sydney" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD010239.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010239.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010239.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010239.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Resuscitation [adverse effects, methods]; Cerebral Hemorrhage [epidemiology]; Enterocolitis, Necrotizing [epidemiology]; Infant Mortality; Infant, Premature [*blood]; Intubation, Intratracheal [statistics &amp; numerical data]; Lung Diseases [epidemiology]; Neurodevelopmental Disorders [epidemiology, etiology]; Oxygen [*administration &amp; dosage, *analysis]; Randomized Controlled Trials as Topic; Retinopathy of Prematurity [epidemiology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010239.pub2&amp;doi=10.1002/14651858.CD010239.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="JmNqPX1V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010239\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010239\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010239.pub2",title:"Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth",firstPublishedDate:"May 4, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010239.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010239.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010239.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010239.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010239.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010239.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010239.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010239.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010239.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010239.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3400 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010239.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0127"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0038"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0069"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-sec-0118"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/appendices#CD010239-sec-0132"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/table_n/CD010239StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/table_n/CD010239StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Kei Lui</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0003">Lisa J Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0004">Jann P Foster</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0005">Peter G Davis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0006">See Kwee Ching</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0007">Ju Lee Oei</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information#CD010239-cr-0008">David A Osborn</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information/en#CD010239-sec-0258">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010239.pub2">https://doi.org/10.1002/14651858.CD010239.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010239-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010239-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010239-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010239-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010239-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010239-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010239-abs-0001" lang="en"> <section id="CD010239-sec-0001"> <h3 class="title" id="CD010239-sec-0001">Background</h3> <p>Initial resuscitation with air is well tolerated by most infants born at term. However, the optimal fractional inspired oxygen concentration (FiO<sub>2</sub> ‐ proportion of the breathed air that is oxygen) targeted to oxygen saturation (SpO<sub>2</sub> ‐ an estimate of the amount of oxygen in the blood) for infants born preterm is unclear. </p> </section> <section id="CD010239-sec-0002"> <h3 class="title" id="CD010239-sec-0002">Objectives</h3> <p>To determine whether lower or higher initial oxygen concentrations, when titrated according to oxygen saturation targets during the resuscitation of preterm infants at birth, lead to improved short‐ and long‐term mortality and morbidity. </p> </section> <section id="CD010239-sec-0003"> <h3 class="title" id="CD010239-sec-0003">Search methods</h3> <p>We conducted electronic searches of the Cochrane Central Register of Controlled Trials (13 October 2017), Ovid MEDLINE (1946 to 13 October 2017), Embase (1974 to 13 October 2017) and CINAHL (1982 to 13 October 2017); we also searched previous reviews (including cross‐references), contacted expert informants, and handsearched journals. </p> </section> <section id="CD010239-sec-0004"> <h3 class="title" id="CD010239-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (including cluster‐ and quasi‐randomised trials) which enrolled preterm infants requiring resuscitation following birth and allocated them to receive either lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) initial oxygen concentrations titrated to target oxygen saturation. </p> </section> <section id="CD010239-sec-0005"> <h3 class="title" id="CD010239-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the eligibility of studies for inclusion, extracted data and assessed methodological quality. Primary outcomes included mortality near term or at discharge (latest reported) and neurodevelopmental disability. We conducted meta‐analysis using a fixed‐effect model. We assessed the quality of the evidence using GRADE. </p> </section> <section id="CD010239-sec-0006"> <h3 class="title" id="CD010239-sec-0006">Main results</h3> <p>The search identified 10 eligible trials. Meta‐analysis of the 10 included studies (914 infants) showed no difference in mortality to discharge between lower (FiO<sub>2</sub> &lt; 0.4) and higher (FiO<sub>2</sub> ≥ 0.4) initial oxygen concentrations targeted to oxygen saturation (risk ratio (RR) 1.05, 95% confidence interval (CI) 0.68 to 1.63). We identified no heterogeneity in this analysis. We graded the quality of the evidence as low due to risk of bias and imprecision. There were no significant subgroup effects according to inspired oxygen concentration strata (FiO<sub>2</sub> 0.21 versus ≥ 0.4 to &lt; 0.6; FiO<sub>2</sub> 0.21 versus ≥ 0.6 to 1.0; and FiO<sub>2</sub> ≥ 0.3 to &lt; 0.4 versus ≥ 0.6 to 1.0). Subgroup analysis identified a single trial that reported increased mortality from use of lower (FiO<sub>2</sub> 0.21) versus higher (FiO<sub>2</sub> 1.0) initial oxygen concentration targeted to a lowest SpO<sub>2</sub> of less than 85%, whereas meta‐analysis of nine trials targeting a lowest SpO<sub>2</sub> of 85% to 90% found no difference in mortality. </p> <p>Meta‐analysis of two trials (208 infants) showed no difference in neurodevelopmental disability at 24 months between infants receiving lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> &gt; 0.4) initial oxygen concentrations targeted to oxygen saturation. Other outcomes were incompletely reported by studies. Overall, we found no difference in use of intermittent positive pressure ventilation or intubation in the delivery room; retinopathy (damage to the retina of the eyes, measured as any retinopathy and severe retinopathy); intraventricular haemorrhage (any and severe); periventricular leukomalacia (a type of white‐matter brain injury); necrotising enterocolitis (a condition where a portion of the bowel dies); chronic lung disease at 36 weeks' gestation; mortality to follow up; postnatal growth failure; and patent ductus arteriosus. We graded the quality of the evidence for these outcomes as low or very low. </p> </section> <section id="CD010239-sec-0007"> <h3 class="title" id="CD010239-sec-0007">Authors' conclusions</h3> <p>There is uncertainty as to whether initiating post birth resuscitation in preterm infants using lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations, targeted to oxygen saturations in the first 10 minutes, has an important effect on mortality or major morbidity, intubation during post birth resuscitation, other resuscitation outcomes, and long‐term outcomes including neurodevelopmental disability. We assessed the quality of the evidence for all outcomes as low to very low. Further large, well designed trials are needed to assess the effect of using different initial oxygen concentrations and the effect of targeting different oxygen saturations. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010239-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010239-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010239-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010239-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010239-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010239-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010239-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010239-abs-0005" lang="en"> <h3>Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth </h3> <p><b>Background</b> </p> <p>For infants born at full term, the use of air (21% oxygen) for resuscitation is generally well tolerated and may be associated with better outcomes. Infants born preterm (before 37 weeks' gestation) require more resuscitation after birth and have more problems with adaptation to life. </p> <p><b>Review question</b> </p> <p>This review set out to investigate whether the use of lower or higher concentrations of oxygen (adjusted according to the infant's oxygen saturation, or percentage of hemoglobin binding sites in the bloodstream occupied by oxygen) are better for resuscitating preterm infants, when used in the first ten minutes after birth. </p> <p><b>Results</b> </p> <p>We included ten trials in this review. The trials included a total of 914 infants, the majority of which were born before 32 weeks' gestation. The review found no evidence of an effect from use of a lower compared to a higher initial oxygen concentration targeted to infant oxygen saturation for resuscitation on mortality or other newborn health outcomes. There was also no difference in the rate of airway intubation (placement of a flexible plastic tube into the windpipe) during resuscitation between the infants who received lower concentrations of oxygen and those who received higher concentrations of oxygen. There was not enough information to determine the effect on long‐term outcomes including neurodevelopmental disability (impairment in physical, learning, language, or behaviour areas). We judged the overall quality of the evidence to be low because of the uncertainty of the effects we found and also because we had concerns about the way in which many of the studies were carried out. The evidence in this review is current to October 2017. </p> <p><b>Conclusions</b> </p> <p>When targeted to the infant's oxygen saturation, it is currently unclear whether the initial oxygen concentration used for resuscitation of preterm infants affects short‐ or long‐term infant outcomes. Further trials enrolling preterm infants at birth assessing both the initial oxygen concentration and the best level of oxygen saturation to target are needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010239-sec-0127" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010239-sec-0127"></div> <h3 class="title" id="CD010239-sec-0128">Implications for practice</h3> <section id="CD010239-sec-0128"> <p>There is uncertainty as to whether initiating post birth resuscitation in preterm infants using lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations, targeted to oxygen saturations in the first 10 minutes, has an important effect on mortality or major morbidity, intubation during post birth resuscitation, other resuscitation outcomes, and long‐term outcomes including neurodevelopmental disability. The evidence was assessed as low‐ to very low‐quality for all outcomes. </p> </section> <h3 class="title" id="CD010239-sec-0129">Implications for research</h3> <section id="CD010239-sec-0129"> <p>Comparing initiating post birth resuscitation in preterm infants using lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations, targeted to oxygen saturations in the first 10 minutes, the finding of no difference in mortality lacks precision so important differences may not have been detected. In addition, the quality of evidence we identified was compromised due to methodological concerns including the potential for selection and performance bias. Further large, well designed trials are needed to assess the effect of using different initial oxygen concentrations. </p> <p>In subgroup analysis we identified a single trial that reported increased mortality from use of lower (FiO<sub>2</sub> 0.21) versus higher (FiO<sub>2</sub> 1.0) oxygen concentrations targeted to a lowest SpO<sub>2</sub> &lt; 85%, whereas meta‐analysis of nine trials targeting a lowest SpO<sub>2</sub> of 85% to 90% found no difference in mortality. Further large, well designed trials are needed to assess the effect of targeting different oxygen saturations in the first 10 minutes after birth. Neurodevelopmental outcomes should be reported. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010239-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010239-sec-0029"></div> <div class="table" id="CD010239-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations titrated to oxygen saturations during resuscitation of preterm infants at birth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants<br/> <b>Settings:</b> at birth<br/> <b>Intervention:</b> lower oxygen concentrations (FiO<sub>2</sub> &lt; 0.4) titrated to oxygen saturations during resuscitation<br/> <b>Comparison:</b> higher oxygen concentrations (FiO<sub>2</sub> ≥ 0.4) titrated to oxygen saturations during resuscitation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality, near term corrected age or discharge</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.05</b> <br/> (0.68 to 1.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>914<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>single study targeting lowest SpO<sub>2</sub> &lt; 85% reported increased mortality for infants resuscitated with air compared to 100% oxygen (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). </p> <p>Meta‐analysis of 9 studies (627 infants) targeting lowest SpO<sub>2</sub> 85% to 90% found no difference in mortality. </p> <p>No subgroup differences according to inspired oxygen concentration strata, highest SpO<sub>2</sub> limit, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>76 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 1000</b><br/> (52 to 124) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b><br/> (46 to 111) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Neurodevelopmental disability</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.82</b> <br/> (0.49 to 1.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>208<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>both studies compared FiO<sub>2</sub> ≥ 0.3 to &lt; 0.4 versus FiO<sub>2</sub> ≥ 0.6 to 1.0 and had a lowest SpO<sub>2</sub> target 85 to 90%. </p> <p>Quality of evidence downgraded due to inconsistency and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>199 per 1000</b><br/> (119 to 327) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>170 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>139 per 1000</b><br/> (83 to 230) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Intubation in the delivery room</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.98</b> <br/> (0.82 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>875<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>352 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>345 per 1000</b><br/> (289 to 416) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>386 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>378 per 1000</b><br/> (317 to 455) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Severe retinopathy of prematurity (≥ stage 3)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.57</b> <br/> (0.24 to 1.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>453<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>58 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b><br/> (14 to 79) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b><br/> (17 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Severe intraventricular haemorrhage (grade 3 or 4)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.93</b> <br/> (0.51 to 1.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>596<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b><br/> (32 to 108) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>73 per 1000</b><br/> (40 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.98</b> <br/> (0.51 to 1.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>807<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b><br/> (24 to 88) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b><br/> (21 to 77) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Chronic lung disease (36 weeks' corrected age)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.91</b> <br/> (0.72 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>862<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias, inconsistency and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>269 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>244 per 1000</b><br/> (193 to 306) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>228 per 1000</b><br/> (180 to 285) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>FiO<sub>2</sub>:</b> fractional inspired oxygen;<b>SpO<sub>2</sub>:</b> oxygen saturation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Two studies at low risk of bias.<br/> <sup>2</sup> Wide confidence intervals. <br/> <sup>3</sup> Moderate heterogeneity. <br/> <sup>4</sup> A single study at low risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010239-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010239-sec-0030"></div> <section id="CD010239-sec-0031"> <h3 class="title" id="CD010239-sec-0031">Description of the condition</h3> <p>Until the past decade, 100% oxygen was recommended as the gas of choice for all full term and preterm infants requiring resuscitation at birth (<a href="./references#CD010239-bbs2-0043" title="O'DonnellCP , GibsonAT , DavisPG . Pinching, electrocution, raven's beaks, and positive pressure ventilation: a brief history of neonatal resuscitation. Archives of Diseases in Childhood. Fetal and Neonatal Edition2006;91(5):F369‐73. [DOI: 10.1136/adc.2005.089029; PUBMED: 16923936] ">O'Donnell 2006</a>; <a href="./references#CD010239-bbs2-0035" title="FinerN , SaugstadO , VentoM , BarringtonK , DavisP , DuaraS , et al. Use of oxygen for resuscitation of the extremely low birth weight infant. Pediatrics2010;125(2):389‐91. [DOI: 10.1542/peds.2009‐1247; PUBMED: 20100772] ">Finer 2010</a>). Oxygen has the potential for both beneficial and deleterious effects (<a href="./references#CD010239-bbs2-0033" title="DucG , SinclairJC . Oxygen administration. In: SinclairJC , BrackenMB editor(s). Effective Care of the Newborn Infant. New York: Oxford University Press, 1992:178‐94. ">Duc 1992</a>). In the minutes after birth many preterm infants, particularly the very preterm, have lung pathology that often requires respiratory assistance and supplemental oxygen. Acute asphyxia can lead to brain hypoxia and ischaemia. These physiological processes can lead to death and morbidity (<a href="./references#CD010239-bbs2-0046" title="PerlmanJM . Brain injury in the term infant. Seminars in Perinatology2004;28(6):415‐24. [PUBMED: 15693398] ">Perlman 2004</a>). For example, intraventricular haemorrhage is now thought to be caused by capillary bleeding from an abrupt alteration in cerebral blood flow and pressure. Conversely, hyperoxia has also been found to slow cerebral blood flow in term and preterm infants (<a href="./references#CD010239-bbs2-0042" title="NiijimaS , ShortlandDB , LeveneMI , EvansDH . Transient hyperoxia and cerebral blood flow velocity in infants born prematurely and at full term. Archives of Diseases in Childhood1988;63(10 Spec No):1126‐30. [PUBMED: 3196067] ">Niijima 1988</a>). In addition, the antioxidant defence system is immature in preterm infants and they are more susceptible to the effects of free oxygen radical damage (<a href="./references#CD010239-bbs2-0034" title="FinerN , LeoneT . Oxygen saturation monitoring for the preterm infant: the evidence basis for current practice. Pediatric Research2009;65(4):375‐80. [DOI: 10.1203/PDR.0b013e318199386a; PUBMED: 19127213] ">Finer 2009</a>; <a href="./references#CD010239-bbs2-0035" title="FinerN , SaugstadO , VentoM , BarringtonK , DavisP , DuaraS , et al. Use of oxygen for resuscitation of the extremely low birth weight infant. Pediatrics2010;125(2):389‐91. [DOI: 10.1542/peds.2009‐1247; PUBMED: 20100772] ">Finer 2010</a>; <a href="./references#CD010239-bbs2-0055" title="SilversKM , GibsonAT , RussellJM , PowersHJ . Antioxidant activity, packed cell transfusions, and outcome in premature infants. Archives of Diseases in Childhood. Fetal and Neonatal Edition1998;78(3):F214‐9. [PUBMED: 9713035] ">Silvers 1998</a>; <a href="./references#CD010239-bbs2-0057" title="VarsilaE , PesonenE , AnderssonS . Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatrica1995;84(11):1296‐9. [PUBMED: 8580630] ">Varsila 1995</a>). Oxidative stress caused by free oxygen radicals is associated with significant injury to the brain, lungs, heart, eyes (<a href="./references#CD010239-bbs2-0028" title="CastilloA , SolaA , BaqueroH , NeiraF , AlvisR , DeulopfutR , et al. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range?. Pediatrics2008;121(5):882‐9. [DOI: 10.1542/peds.2007‐0117; PUBMED: 18450890] ">Castillo 2008</a>; <a href="./references#CD010239-bbs2-0054" title="ShiaoSY , OuCN , PierantoniH . The measurement of accurate fetal hemoglobin and related oxygen saturation by the hemoximeter. Clinica Chimica Acta2006;374(1‐2):75‐80. [DOI: 10.1016/j.cca.2006.05.042; PUBMED: 16844104] ">Shiao 2006</a>; <a href="./references#CD010239-bbs2-0061" title="VentoM , SastreJ , AsensiMA , ViñaJ . Room‐air resuscitation causes less damage to heart and kidney than 100% oxygen. American Journal of Respiratory and Critical Care Medicine2005;172(11):1393‐8. ">Vento 2005</a>), and neonatal bowel (<a href="./references#CD010239-bbs2-0029" title="CzyrkoC , SteigmanC , TurleyDL , DrottHR , ZieglerMM . The role of reperfusion injury in occlusive intestinal ischemia of the neonate: malonaldehyde‐derived fluorescent products and correlation of histology. Journal of Surgical Research1991;51(1):1‐4. [PUBMED: 2067352] ">Czyrko 1991</a>). Oxygen free radicals are released during the recovery or reperfusion period and excessive oxidative stress can lead to further tissue damage in preterm infants, such as that seen in hypoxic‐ischaemic brain injury (<a href="./references#CD010239-bbs2-0032" title="du PlessisAJ , JohnstonMV . Hypoxic‐ischemic brain injury in the newborn. Cellular mechanisms and potential strategies for neuroprotection. Clinics in Perinatology1997;24(3):627‐54. [PUBMED: 9394864] ">du Plessis 1997</a>), retinopathy of prematurity (ROP), chronic lung disease (CLD) (<a href="./references#CD010239-bbs2-0034" title="FinerN , LeoneT . Oxygen saturation monitoring for the preterm infant: the evidence basis for current practice. Pediatric Research2009;65(4):375‐80. [DOI: 10.1203/PDR.0b013e318199386a; PUBMED: 19127213] ">Finer 2009</a>; <a href="./references#CD010239-bbs2-0035" title="FinerN , SaugstadO , VentoM , BarringtonK , DavisP , DuaraS , et al. Use of oxygen for resuscitation of the extremely low birth weight infant. Pediatrics2010;125(2):389‐91. [DOI: 10.1542/peds.2009‐1247; PUBMED: 20100772] ">Finer 2010</a>), and cerebral palsy (CP) (<a href="./references#CD010239-bbs2-0041" title="KlingerG , BeyeneJ , ShahP , PerlmanM . Do hyperoxaemia and hypocapnia add to the risk of brain injury after intrapartum asphyxia?. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(1):F49‐52. [DOI: 10.1136/adc.2003.048785; PUBMED: 15613575] ">Klinger 2005</a>). CLD is a serious condition that results in chronic inflammation and fibrosis in the infant lung with recurring cycles of lung damage and repair that may impair alveolarization and vascularization in the developing lungs (<a href="./references#CD010239-bbs2-0037" title="HayesDJr , FeolaDJ , MurphyBS , ShookLA , BallardHO . Pathogenesis of bronchopulmonary dysplasia. Respiration2010;79(5):425‐36. [DOI: 10.1159/000242497; PUBMED: 19786727] ">Hayes 2010</a>). ROP is characterised by abnormal retinal vascular development and remains a major cause of blindness and visual impairment despite improvements in neonatal care (<a href="./references#CD010239-bbs2-0050" title="RomagnoliC . Risk factors and growth factors in ROP. Early Human Development2009;85(10 Suppl):79‐82. [DOI: 10.1016/j.earlhumdev.2009.08.026; PUBMED: 19828269] ">Romagnoli 2009</a>). </p> </section> <section id="CD010239-sec-0032"> <h3 class="title" id="CD010239-sec-0032">Description of the intervention</h3> <p>The aim of resuscitation is to prevent death and adverse long‐term neurodevelopmental sequelae (<a href="./references#CD010239-bbs2-0030" title="DavisPG , TanA , O'DonnellCF , SchulzeA . Resuscitation of newborn infants with 100% oxygen or air: a systematic review and meta‐analysis. Lancet2004;364(9442):1329‐33. [DOI: 10.1016/S0140‐6736(04)17189‐4; PUBMED: 15474135] ">Davis 2004</a>). Accumulating evidence over the last decade has challenged clinicians to reconsider the optimal oxygen concentration for resuscitation of the newborn term infant (<a href="./references#CD010239-bbs2-0058" title="VentoM , AsensiM , SastreJ , García‐SalaF , PallardóFV , ViñaJ . Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics2001;107(4):642‐7. [PUBMED: 11335737] ">Vento 2001</a>; <a href="./references#CD010239-bbs2-0059" title="VentoM , AsensiM , SastreJ , LloretA , García‐SalaF , MiñanaJB , et al. Hyperoxemia caused by resuscitation with pure oxygen may alter intracellular redox status by increasing oxidized glutathione in asphyxiated newly born infants. Seminars in Perinatology2002;26(6):406‐10. [PUBMED: 12537311] ">Vento 2002</a>; <a href="./references#CD010239-bbs2-0060" title="VentoM , AsensiM , SastreJ , LloretA , García‐SalaF , ViñaJ . Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. Journal of Pediatrics2003;142(3):240‐6. [PUBMED: 12640369] ">Vento 2003</a>; <a href="./references#CD010239-bbs2-0061" title="VentoM , SastreJ , AsensiMA , ViñaJ . Room‐air resuscitation causes less damage to heart and kidney than 100% oxygen. American Journal of Respiratory and Critical Care Medicine2005;172(11):1393‐8. ">Vento 2005</a>). A number of studies have compared varying concentrations of oxygen at resuscitation without targeting a predetermined oxygen saturation range in term infants (for example: <a href="./references#CD010239-bbs2-0020" title="SaugstadOD , RamjiS , IraniSF , El‐MenezaS , HernandezEA , VentoM , et al. Resuscitation of newborn infants with 21% or 100% oxygen: follow‐up at 18 to 24 months. Pediatrics2003;112(2):296‐300. [PUBMED: 12897277] SaugstadOD , RootweltT , AalenO . Resuscitation of asphyxiated newborn infants with room air or oxygen: an international controlled trial: the Resair 2 study. Pediatrics1998;102(1):e1. [PUBMED: 9651453] ">Saugstad 1998</a> ‐ 21% versus 100%; <a href="./references#CD010239-bbs2-0058" title="VentoM , AsensiM , SastreJ , García‐SalaF , PallardóFV , ViñaJ . Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics2001;107(4):642‐7. [PUBMED: 11335737] ">Vento 2001</a> ‐ 21% versus 100%; <a href="./references#CD010239-bbs2-0015" title="HarlingAE , BeresfordMW , VinceGS , BatesM , YoxallCW . Does the use of 50% oxygen at birth in preterm infants reduce lung injury?. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F401‐5. [DOI: 10.1136/adc.2004.059287; PUBMED: 15863491] ">Harling 2005</a> ‐ 50% versus 100%). </p> <p>Several systematic reviews have compared the use of 100% and 21% oxygen during resuscitation of preterm and term infants (<a href="./references#CD010239-bbs2-0030" title="DavisPG , TanA , O'DonnellCF , SchulzeA . Resuscitation of newborn infants with 100% oxygen or air: a systematic review and meta‐analysis. Lancet2004;364(9442):1329‐33. [DOI: 10.1016/S0140‐6736(04)17189‐4; PUBMED: 15474135] ">Davis 2004</a>; <a href="./references#CD010239-bbs2-0052" title="SaugstadOD , RamjiS , SollRF , VentroM . Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic review and meta‐analysis. Neonatology2008;94(3):176‐82. [DOI: 10.1159/000143397; PUBMED: 18612215] ">Saugstad 2008</a>; <a href="./references#CD010239-bbs2-0056" title="TanA , SchulzeA , O'DonnellCF , DavisPG . Air versus oxygen for resuscitation of infants at birth. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002273.pub3] ">Tan 2005</a>). A Cochrane review found a reduction in mortality in infants resuscitated with room air and no evidence of adverse effects (<a href="./references#CD010239-bbs2-0056" title="TanA , SchulzeA , O'DonnellCF , DavisPG . Air versus oxygen for resuscitation of infants at birth. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002273.pub3] ">Tan 2005</a>). However, more than a quarter of the infants randomised to 21% oxygen (room air) required supplemental oxygen. A planned subgroup analysis based on gestational age was not possible as the results of individual studies were not stratified by gestational age. One study similarly reported that the relative risk of mortality was less when 21% oxygen rather than 100% oxygen was used as the resuscitation gas (<a href="./references#CD010239-bbs2-0052" title="SaugstadOD , RamjiS , SollRF , VentroM . Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic review and meta‐analysis. Neonatology2008;94(3):176‐82. [DOI: 10.1159/000143397; PUBMED: 18612215] ">Saugstad 2008</a>). </p> <p>Recently there has been an increased interest in titrating oxygen concentrations according to oxygen saturation range. A randomised controlled trial studied oxidative stress in preterm infants who were resuscitated with 100% oxygen throughout the resuscitation (without oxygen saturation targeting) versus preterm infants who were initially given 100% oxygen and titrated according to a predetermined target oxygen saturation (90 to 95%) (<a href="./references#CD010239-bbs2-0013" title="EzakiS , SuzukiK , KurishimaC , MiuraM , WeilinW , HoshiR , et al. Resuscitation of preterm infants with reduced oxygen results in less oxidative stress than resuscitation with 100% oxygen. Journal of Clinical Biochemistry and Nutrition2009;44(1):111‐8. [DOI: 10.3164/jcbn.08‐221; PUBMED: 19177196] ">Ezaki 2009</a>). These authors concluded that oxidative stress may be reduced by titrating oxygen concentrations according to targeted oxygen saturations during resuscitation. An observational study compared preterm infants receiving 100% oxygen throughout the entire resuscitation with those that initially received 21% oxygen and then were titrated according to a predetermined target oxygen saturation (80% to 90%) (<a href="./references#CD010239-bbs2-0012" title="DawsonJA , KamlinCO , WongC , tePasAB , O'DonnellCF , DonathSM , et al. Oxygen saturation and heart rate during delivery room resuscitation of infants &lt;30 weeks' gestation with air or 100% oxygen. Archives of Disease in Childhood. Fetal and Neonatal Edition2009;94(2):F87‐91. [DOI: 10.1136/adc.2008.141341; PUBMED: 18703572] ">Dawson 2009</a>). The authors also concluded that it is possible to adjust the fraction of inspired oxygen (FiO<sub>2</sub>) to keep peripheral oxygen saturation (SpO<sub>2</sub>) measurements within a targeted range during resuscitation. However, 92% of infants resuscitated with 21% oxygen required supplemental oxygen. Thus, this review assesses trials that have compared lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation for preterm infants at birth. </p> </section> <section id="CD010239-sec-0033"> <h3 class="title" id="CD010239-sec-0033">How the intervention might work</h3> <p>The first minutes of transition from fetal to neonatal life require a unique adjustment from lower to higher environmental oxygen exposure. Oxygen saturations are lower in utero than ex utero, and the rate of change from fetal to neonatal values has been shown to be a more gradual process than we previously believed. The natural history of the transition from fetal to neonatal blood oxygen saturations has been documented to be a slow but steady increase in the first five to 10 minutes of life (<a href="./references#CD010239-bbs2-0035" title="FinerN , SaugstadO , VentoM , BarringtonK , DavisP , DuaraS , et al. Use of oxygen for resuscitation of the extremely low birth weight infant. Pediatrics2010;125(2):389‐91. [DOI: 10.1542/peds.2009‐1247; PUBMED: 20100772] ">Finer 2010</a>). Fetal oxygen partial pressures (PaO<sub>2</sub>) are in the 15 mmHg to 30 mmHg range, resulting in a fetal SpO<sub>2</sub> range of 45% to 55%. After delivery, these pressures will normally rise over the next few minutes to between 50 mmHg and 80 mmHg (<a href="./references#CD010239-bbs2-0040" title="KamlinCO , O'DonnellCP , DavisPG , MorleyCJ . Oxygen saturation in healthy infants immediately after birth. Journal of Pediatrics2006;148(5):585‐9. [DOI: 10.1016/j.jpeds.2005.12.050; PUBMED: 16737865] ">Kamlin 2006</a>; <a href="./references#CD010239-bbs2-0048" title="RabiY , YeeW , ChenSY , SinghalN . Oxygen saturation trends immediately after birth. Journal of Pediatrics2006;148(5):590‐4. [DOI: 10.1016/j.jpeds.2005.12.047; PUBMED: 16737866] ">Rabi 2006</a>), depending on the status of the lungs, the pulmonary circulation, and the presence of other stressors at delivery. It has been shown that the oxygen saturation of healthy preterm infants rises gradually after birth and only reaches 90% saturation readings by a median of seven minutes of life (<a href="./references#CD010239-bbs2-0040" title="KamlinCO , O'DonnellCP , DavisPG , MorleyCJ . Oxygen saturation in healthy infants immediately after birth. Journal of Pediatrics2006;148(5):585‐9. [DOI: 10.1016/j.jpeds.2005.12.050; PUBMED: 16737865] ">Kamlin 2006</a>; <a href="./references#CD010239-bbs2-0048" title="RabiY , YeeW , ChenSY , SinghalN . Oxygen saturation trends immediately after birth. Journal of Pediatrics2006;148(5):590‐4. [DOI: 10.1016/j.jpeds.2005.12.047; PUBMED: 16737866] ">Rabi 2006</a>). It is postulated that resuscitation with oxygen titrated on the basis of targeted saturations can mimic the oxygen saturations of transitioning preterm infants not needing resuscitation, with a resultant physiological rise of oxygen saturation. Thus, the goal of oxygen saturation targeting is to reduce total oxygen load while 'normal and adequate' oxygen saturation and tissue oxygenation is maintained. Pulse oximetry allows clinicians to continuously monitor and target oxygen saturations within a defined range (<a href="./references#CD010239-bbs2-0033" title="DucG , SinclairJC . Oxygen administration. In: SinclairJC , BrackenMB editor(s). Effective Care of the Newborn Infant. New York: Oxford University Press, 1992:178‐94. ">Duc 1992</a>). Thus, rather than resuscitating infants with a predetermined oxygen concentration such as 100% or 21% throughout the resuscitation, it has been proposed that titrating oxygen concentrations, for example increasing the initial concentration from 21% oxygen or decreasing initial concentration from 100% according to a predetermined oxygen saturation range, helps prevent hypoxia or hyperoxia or oxidative stress in premature infants (<a href="./references#CD010239-bbs2-0012" title="DawsonJA , KamlinCO , WongC , tePasAB , O'DonnellCF , DonathSM , et al. Oxygen saturation and heart rate during delivery room resuscitation of infants &lt;30 weeks' gestation with air or 100% oxygen. Archives of Disease in Childhood. Fetal and Neonatal Edition2009;94(2):F87‐91. [DOI: 10.1136/adc.2008.141341; PUBMED: 18703572] ">Dawson 2009</a>; <a href="./references#CD010239-bbs2-0013" title="EzakiS , SuzukiK , KurishimaC , MiuraM , WeilinW , HoshiR , et al. Resuscitation of preterm infants with reduced oxygen results in less oxidative stress than resuscitation with 100% oxygen. Journal of Clinical Biochemistry and Nutrition2009;44(1):111‐8. [DOI: 10.3164/jcbn.08‐221; PUBMED: 19177196] ">Ezaki 2009</a>; <a href="./references#CD010239-bbs2-0034" title="FinerN , LeoneT . Oxygen saturation monitoring for the preterm infant: the evidence basis for current practice. Pediatric Research2009;65(4):375‐80. [DOI: 10.1203/PDR.0b013e318199386a; PUBMED: 19127213] ">Finer 2009</a>; <a href="./references#CD010239-bbs2-0035" title="FinerN , SaugstadO , VentoM , BarringtonK , DavisP , DuaraS , et al. Use of oxygen for resuscitation of the extremely low birth weight infant. Pediatrics2010;125(2):389‐91. [DOI: 10.1542/peds.2009‐1247; PUBMED: 20100772] ">Finer 2010</a>). </p> </section> <section id="CD010239-sec-0034"> <h3 class="title" id="CD010239-sec-0034">Why it is important to do this review</h3> <p>The use of oxygen during the resuscitation of preterm infants has become an increasingly controversial issue (<a href="./references#CD010239-bbs2-0047" title="PerlmanJM , KattwinkelJ . Delivery room resuscitation past, present, and the future. Clinics in Perinatology2006;33(1):1‐9. [DOI: 10.1016/j.clp.2005.11.004; PUBMED: 16533629] ">Perlman 2006</a>). There is a growing body of evidence that resuscitation with air is well tolerated in most term infants (<a href="./references#CD010239-bbs2-0047" title="PerlmanJM , KattwinkelJ . Delivery room resuscitation past, present, and the future. Clinics in Perinatology2006;33(1):1‐9. [DOI: 10.1016/j.clp.2005.11.004; PUBMED: 16533629] ">Perlman 2006</a>; <a href="./references#CD010239-bbs2-0056" title="TanA , SchulzeA , O'DonnellCF , DavisPG . Air versus oxygen for resuscitation of infants at birth. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002273.pub3] ">Tan 2005</a>). However, the optimal oxygen concentration for preterm infants, who often have some element of pulmonary disease and usually require more intensive resuscitation, are less clear (<a href="./references#CD010239-bbs2-0047" title="PerlmanJM , KattwinkelJ . Delivery room resuscitation past, present, and the future. Clinics in Perinatology2006;33(1):1‐9. [DOI: 10.1016/j.clp.2005.11.004; PUBMED: 16533629] ">Perlman 2006</a>). The question as to whether lower or higher initial oxygen concentrations that are titrated according to oxygen saturation targets during the resuscitation of preterm infants at birth would lead to improved short‐ and long‐term mortality and morbidity remains unanswered. Therefore, it is currently difficult for clinicians to make informed decisions regarding the use of oxygen in preterm infants. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010239-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010239-sec-0035"></div> <p>To determine whether lower or higher initial oxygen concentrations, when titrated according to oxygen saturation targets during the resuscitation of preterm infants at birth, lead to improved short‐ and long‐term mortality and morbidity. </p> <section id="CD010239-sec-0036"> <h3 class="title" id="CD010239-sec-0036">Primary comparison</h3> <p> <ul id="CD010239-list-0001"> <li> <p>Any of the lower concentrations of oxygen (21%, air; &gt; 21% to 29%, very low; ≥ 30% to 39%, low) versus any of the higher concentrations of oxygen (≥ 40% to 59%, high; ≥ 60% to 100%, very high). </p> </li> </ul> </p> <p>The primary comparison was analysed by the following subgroups:</p> <p> <ul id="CD010239-list-0002"> <li> <p>targeted oxygen saturation (lower or higher limit for oxygen saturation target range for titration &lt; 85%; 85% to 90%; 91% to 95%; &gt; 95%); </p> </li> </ul> <ul id="CD010239-list-0003"> <li> <p>type of oxygen saturation monitor (fractional or functional oxygen saturation);</p> </li> </ul> <ul id="CD010239-list-0004"> <li> <p>gestation (&lt; 28 weeks; 28 weeks to 32 weeks; 33 to 36 weeks).</p> </li> </ul> </p> </section> <section id="CD010239-sec-0037"> <h3 class="title" id="CD010239-sec-0037">Secondary analyses</h3> <p>We did not include studies comparing two oxygen concentrations considered to be either in the lower or the higher ranges in the primary analyses. We planned to perform secondary analyses for studies comparing two groups that were both in the lower, or higher, oxygen concentration range (for example, 50% versus 100%). </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010239-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010239-sec-0038"></div> <section id="CD010239-sec-0039"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010239-sec-0040"> <h4 class="title">Types of studies</h4> <p>We considered all published and unpublished randomised or quasi‐randomised trials, including cluster‐randomised trials. </p> </section> <section id="CD010239-sec-0041"> <h4 class="title">Types of participants</h4> <p>Preterm infants &lt; 37 weeks' gestation that required resuscitation at birth.</p> </section> <section id="CD010239-sec-0042"> <h4 class="title">Types of interventions</h4> <p>Lower versus higher oxygen concentrations (fraction of inspired oxygen (FiO<sub>2</sub>) &lt; 0.4 or FiO<sub>2</sub> ≥ 0.4 as initial gas mixtures) to targeted oxygen saturation during resuscitation at birth. We did not include trials comparing different O<sub>2</sub> saturation targets. </p> <p>Both groups must have had the same targeted oxygen saturation.</p> <p>Trials were eligible for inclusion if the intervention groups shared similar oxygenation saturation targeting at any time during resuscitation or during initial neonatal intensive care unit (NICU) admission (or both) for the first 30 minutes. </p> </section> <section id="CD010239-sec-0043"> <h4 class="title">Types of outcome measures</h4> <section id="CD010239-sec-0044"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010239-list-0005"> <li> <p>Mortality, near term corrected or at discharge (latest reported).</p> </li> <li> <p>Neurodevelopmental disability (after at least 18 months postnatal age):</p> </li> </ul> <ul class="plain" id="CD010239-list-0006"> <li> <ul id="CD010239-list-0007"> <li> <p>neurological abnormality including cerebral palsy on clinical examination, developmental delay more than two standard deviations below population mean on any standard test of development; </p> </li> <li> <p>blindness (visual acuity &lt; 6/60);</p> </li> <li> <p>deafness (any hearing impairment requiring amplification).</p> </li> </ul> </li> </ul> </p> </section> <section id="CD010239-sec-0045"> <h5 class="title">Secondary outcomes</h5> <section id="CD010239-sec-0046"> <h6 class="title">Response to resuscitation</h6> <p> <ul id="CD010239-list-0008"> <li> <p>need for intermittent positive pressure ventilation (IPPV) in the delivery room;</p> </li> <li> <p>need for intubation in the delivery room;</p> </li> <li> <p>time to reach desired oxygen saturation target (seconds or minutes).</p> </li> <li> <p>time to reach heart rate &gt; 100 beats per minute (bpm) (seconds or minutes).</p> </li> </ul> </p> </section> <section id="CD010239-sec-0047"> <h6 class="title">Neonatal outcomes</h6> <p> <ul id="CD010239-list-0009"> <li> <p>retinopathy of prematurity (ROP) (any; severe (stage ≥ 3));</p> </li> <li> <p>intraventricular haemorrhage (IVH) (any; severe (stage ≥ 3)) according to Papile classification (<a href="./references#CD010239-bbs2-0045" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1,500 gm. Journal of Pediatrics1978;92(4):529‐34. [PUBMED: 305471] ">Papile 1978</a>); </p> </li> <li> <p>periventricular leukomalacia (PVL) (cystic);</p> </li> <li> <p>hypoxic ischaemic encephalopathy (HIE) Grade 1 to 3 (<a href="./references#CD010239-bbs2-0051" title="SarnatHB , SarnatMS . Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Archives of Neurology1976;33(10):696‐705. [PUBMED: 987769] ">Sarnat 1976</a>); </p> </li> <li> <p>necrotising enterocolitis (proven = Bell stage ≥ 2) (<a href="./references#CD010239-bbs2-0026" title="BellMJ , TernbergJL , FeiginRD , KeatingJP , MarshallR , BartonL , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery1978;187(1):1‐7. [PUBMED: 413500] ">Bell 1978</a>); </p> </li> <li> <p>chronic lung disease (need for supplemental oxygen at 28 days of life; need for supplemental oxygen at 36 weeks' postmenstrual age for infants born at or before 32 weeks' gestation); </p> </li> <li> <p>duration of respiratory support (mechanical ventilation, continuous positive airway pressure (CPAP)) (days from birth); </p> </li> <li> <p>duration of supplemental oxygen administration (days from birth);</p> </li> <li> <p>late mortality (after at least 18 months postnatal age);</p> </li> <li> <p>postnatal growth failure (weight &lt; 10th percentile at discharge); and</p> </li> <li> <p>duration of hospitalisation (days from birth).</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD010239-sec-0048"> <h3 class="title">Search methods for identification of studies</h3> <p>We used the standard search strategy of the Cochrane Neonatal Review Group (CNRG) as outlined in the <i>Cochrane Library</i>. See: <a href="./appendices#CD010239-sec-0133">Appendix 1</a>. </p> <section id="CD010239-sec-0049"> <h4 class="title">Electronic searches</h4> <p>Two review authors performed the electronic database searches independently. This included electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (January 2017), Ovid MEDLINE (1946 to January 2017), Embase (1974 to January 2017) and CINAHL (1982 to January 2017). We updated these searches on 13 October 2017. </p> <p>We searched MEDLINE, Embase and CINAHL for relevant articles using: (oxygen.mp. or exp oxygen/) AND (exp resuscitation/ or resuscitation.mp.) AND (exp prematurity/ or preterm.mp or premature.mp). Searches were limited to: MEDLINE ‐ humans and clinical trial, all; Embase ‐ human and (clinical trial or randomised controlled trial or controlled clinical trial or multicenter study or phase 1 clinical trial or phase 2 clinical trial or phase 3 clinical trial or phase 4 clinical trial). </p> <p>MeSH terms "infant, newborn" or "infant, newborn diseases" or text term "neonat*" AND Resuscitation (explode) [MeSH heading] AND Oxygen (explode) [MeSH heading]. </p> <p>We searched clinical trials registries for current or recently completed trials (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; <a href="http://www.isrctn.com/" target="_blank">controlled‐trials.com</a>; <a href="http://www.who.int/ictrp/en/" target="_blank">who.int/ictrp</a>). </p> </section> <section id="CD010239-sec-0050"> <h4 class="title">Searching other resources</h4> <p>We also included in our search strategy communication with expert informants; searches of the bibliographies of reviews and trials for references to other trials; previous reviews including cross‐references; abstracts, and conferences and symposia proceedings of the Perinatal Society of Australia and New Zealand and Pediatric Academic Societies (American Pediatric Society, Society for Pediatric Research and European Society for Pediatric Research) from 1990 to 2016. We contacted the corresponding investigator for information if we identified any unpublished trial. We considered unpublished studies or studies only reported as abstracts as eligible for inclusion in the review if methods and data could be confirmed by the author. We also contacted the corresponding authors of identified RCTs for additional information about their studies when further data was required. </p> </section> </section> <section id="CD010239-sec-0051"> <h3 class="title" id="CD010239-sec-0051">Data collection and analysis</h3> <p>We used the standard methods of Cochrane as documented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010239-bbs2-0038" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), and recommended by the Cochrane Neonatal Review Group. </p> <section id="CD010239-sec-0052"> <h4 class="title">Selection of studies</h4> <p>Two review authors (DO and LJ) independently screened titles and abstracts. Four review authors (KL, JF, DO, and LJ) independently assessed eligibility of all studies identified in the searches for inclusion in this review from full text. Any differences in opinion were resolved through discussion (KL, PD, DO). </p> </section> <section id="CD010239-sec-0053"> <h4 class="title">Data extraction and management</h4> <p>Four review authors (KL, JF, LJ, DO) independently extracted data from the full‐text articles using a specifically designed spread sheet to manage the information. Any differences in opinion were resolved by discussion. We entered the data into Review Manager software (<a href="./references#CD010239-bbs2-0049" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and cross‐checked entries for accuracy. We sought unpublished data from several authors. </p> </section> <section id="CD010239-sec-0054"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. </p> <p>Review authors (KL, JF, DO and LJ) independently assessed the risk of bias of all included trials using the Cochrane ‘Risk of bias’ tool for the following domains (<a href="./references#CD010239-bbs2-0038" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>): </p> <p> <ul id="CD010239-list-0010"> <li> <p>sequence generation (selection bias);</p> </li> <li> <p>allocation concealment (selection bias);</p> </li> <li> <p>blinding of participants and personnel (performance bias);</p> </li> <li> <p>blinding of outcome assessment (detection bias);</p> </li> <li> <p>incomplete outcome data (attrition bias);</p> </li> <li> <p>selective reporting (reporting bias);</p> </li> <li> <p>any other bias.</p> </li> </ul> </p> <p>For each domain, we assigned a judgement of high, low, or unclear risk of bias. We resolved any disagreements by discussion or by involving another assessor. See <a href="./appendices#CD010239-sec-0134">Appendix 2</a> for a more detailed description of risk of bias for each domain. </p> </section> <section id="CD010239-sec-0055"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed the results of the studies using the statistical package in Review Manager (<a href="./references#CD010239-bbs2-0049" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We summarised the data in a meta‐analysis if they were sufficiently homogeneous, both clinically and statistically. </p> <section id="CD010239-sec-0056"> <h5 class="title">Dichotomous data</h5> <p>We present results as risk ratios (RRs) and risk differences (RDs) with 95% confidence intervals (CIs) for dichotomous data. We intended to calculate the number needed to treat to benefit (NNTB), or number needed to harm (NNTH), and associated 95% CI if there was a statistically significant reduction (or increase) in RD. </p> </section> <section id="CD010239-sec-0057"> <h5 class="title">Continuous data</h5> <p>We used the mean difference (MD) for continuous data when outcomes were measured in the same way between trials. We used the standardised mean difference (SMD) to combine trials that measured the same outcome but use different methods. Where trials reported continuous data as median and interquartile range<b>(</b>IQR) and data passed a test of skewness, we converted mean to median and estimated the standard deviation as IQR/1.35. Where trials reported medians and ranges we used the methods reported by <a href="./references#CD010239-bbs2-0039" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471‐2288‐5‐13] ">Hozo 2005</a>. </p> </section> </section> <section id="CD010239-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participating infant in individually randomised trials. No cluster‐randomised trials were identified. </p> <section id="CD010239-sec-0059"> <h5 class="title">Cluster‐randomised trials</h5> <p>We planned to make adjustments to the standard errors using the methods described in the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD010239-bbs2-0038" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a> section 16.3.6) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study with a similar population. If we used ICCs from other sources, we planned to report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. We consider it reasonable to combine the results from both cluster‐randomised trials and individually randomised trials if there is little heterogeneity between the study designs and the interaction between the effect of the intervention and the choice of randomisation unit is considered to be unlikely. </p> </section> </section> <section id="CD010239-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We noted levels of attrition for included studies. We intended to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. We carried out analyses for all outcomes, as far as possible, on an intention‐to‐treat basis, that is we attempted to include all participants randomised to each group in the analyses, and we analysed all participants in the group to which they were allocated regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD010239-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used Review Manager 5 to assess the heterogeneity of treatment effects between trials (<a href="./references#CD010239-bbs2-0049" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used the Chi<sup>2</sup> test to assess whether observed variability in effect sizes between studies is greater than would be expected by chance. Since this test has low power when the number of studies included in the meta‐analysis is small, we set the probability at the 10% level of significance. </p> <p>We used the I<sup>2</sup> statistic to ensure that pooling of data was valid. We considered a degree of heterogeneity less than 25% to represent no heterogeneity, 25% to 49% may represent minimal heterogeneity, 50% to 74% may represent moderate heterogeneity, and greater than 75% may represent substantial or high heterogeneity. </p> <p>We assessed the source of the heterogeneity using sensitivity and subgroup analyses, looking for evidence of bias or methodological differences between trials where there is evidence of apparent or statistical heterogeneity. </p> </section> <section id="CD010239-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed reporting bias by comparing the stated primary and secondary outcomes and reported outcomes. Where study protocols were available, we compared these to the full publications to determine the likelihood of reporting bias. We investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually; we did not use formal tests. We planned to perform exploratory analyses to investigate if asymmetry was detected by visual assessment. </p> </section> <section id="CD010239-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager (<a href="./references#CD010239-bbs2-0049" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used the fixed‐effect model inverse variance meta‐analysis for combining data where trials examined the same intervention and the populations and methods of the trials were judged to be similar. We intended to assess the possible source(s) of heterogeneity using subgroup and sensitivity analysis. </p> <section id="CD010239-sec-0064"> <h5 class="title">Quality of evidence</h5> <p>We used the GRADE approach, as outlined in the GRADE Handbook (<a href="./references#CD010239-bbs2-0053" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">Schünemann 2013</a>), to assess the quality of evidence for the following (clinically relevant) outcomes: </p> <p> <ul id="CD010239-list-0011"> <li> <p>mortality (near term corrected or at discharge (latest reported));</p> </li> <li> <p>neurodevelopmental disability (after at least 18 months postnatal age);</p> </li> <li> <p>intubation in the delivery room;</p> </li> <li> <p>retinopathy of prematurity (severe, stage ≥ 3);</p> </li> <li> <p>intraventricular haemorrhage (severe, stage ≥ 3);</p> </li> <li> <p>necrotising enterocolitis (proven, = Bell stage ≥ 2);</p> </li> <li> <p>chronic lung disease.</p> </li> </ul> </p> <p>Two review authors independently assessed the quality of the evidence for each of the outcomes above. We considered evidence from randomised controlled trials as high quality but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates, and presence of publication bias. We used <a href="./references#CD010239-bbs2-0036" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 31 March 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a> to create a ‘Summary of findings’ table to report the quality of the evidence (<a href="./references#CD010239-bbs2-0036" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 31 March 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a>). </p> <p>The GRADE approach results in an assessment of the quality of a body of evidence according to one of the following grades. </p> <p> <ul id="CD010239-list-0012"> <li> <p>High: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> </section> </section> <section id="CD010239-sec-0065"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out the following subgroup analyses:</p> <p> <ul id="CD010239-list-0013"> <li> <p>targeted oxygen saturation (low or high upper target limit for titration, &lt; 85%; 85% to 90%; 91% to 95%; &gt; 95%); </p> </li> <li> <p>time taken to reach oxygen saturation target range (within first 10 minutes; within first 20 minutes; within first 30 minutes); </p> </li> <li> <p>type of oxygen saturation monitor (fractional or functional oxygen saturation);</p> </li> <li> <p>gestation (&lt; 28 weeks; 28 to 32 weeks; 33 to 36 weeks).</p> </li> </ul> </p> <section id="CD010239-sec-0066"> <h5 class="title">Secondary analyses</h5> <p>We intended to undertake secondary analyses of studies in which infants in both the intervention and control arms were exposed to the same category (high or low) of supplemental oxygen (these studies were not included in the primary analyses). </p> </section> <section id="CD010239-sec-0067"> <h5 class="title">Strategies for exploring heterogeneity</h5> <p> <ul id="CD010239-list-0014"> <li> <p>Identification of the methodological differences between studies</p> </li> <li> <p>Subgroup analysis</p> </li> <li> <p>Meta‐regression if enough data were available (<a href="./references#CD010239-bbs2-0038" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>) </p> </li> </ul> </p> </section> </section> <section id="CD010239-sec-0068"> <h4 class="title">Sensitivity analysis</h4> <p>We explored methodological heterogeneity through the use of sensitivity analyses, where sufficient data were available. We performed sensitivity analyses through excluding trials of high risk of bias, based on a lack of any of the following: allocation concealment, adequate randomisation, blinding of treatment, less than 10% loss to follow‐up. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010239-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010239-sec-0069"></div> <section id="CD010239-sec-0070"> <h3 class="title">Description of studies</h3> <section id="CD010239-sec-0071"> <h4 class="title">Results of the search</h4> <p>Refer to <a href="#CD010239-fig-0001">Figure 1</a> for a flow diagram of searches. The combined searches of CENTRAL, MEDLINE and Embase returned 313 records. Additional databases (WHO, Maternity and Infant Care, PAS Abstracts, www.clinicaltrials.gov and www.controlledtrials.com) returned 66 records. We assessed 39 full‐text reports for eligibility, of which we excluded 12 studies (14 reports). We identified one study as ongoing, one study as awaiting assessment, and included 10 studies (23 reports) for analysis. This includes a report from our updated search on 13 October 2017, a single additional report of neurodevelopmental outcomes of two trials that are incorporated in the review (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). </p> <div class="figure" id="CD010239-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010239-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010239-sec-0072"> <h4 class="title">Included studies</h4> <p>We identified 10 eligible trials studies comparing lower versus higher oxygen concentrations titrated to targeted oxygen saturations during resuscitation (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). Refer to <a href="./references#CD010239-sec-0264" title="">Characteristics of included studies</a> for details. </p> <section id="CD010239-sec-0073"> <h5 class="title">Participants</h5> <p>The trials took place in a variety of perinatal treatment centres in the Netherlands, Spain, Iran, Qatar, Malaysia, Australia, USA and Canada within the last 12 years. A total of 914 infants participated. All 10 trials enrolled infants on the basis of preterm gestation corresponding to the following subgroups: extremely preterm (&lt; 28 weeks' gestation) (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>); very preterm (28 to &lt; 32 weeks' gestation) (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>); extremely to very preterm (24 to &lt; 32 weeks' gestation) (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>); and very preterm to preterm (28 to &lt; 37 weeks' gestation) (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>). Two studies excluded infants of unknown or uncertain gestational ages (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>). No studies reported on preterm infants born at 32 to &lt; 37 weeks. One study reported subgroups of extremely preterm (100 from 290 enrolled infants) and very preterm (10 from 19 enrolled infants) (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). All ten trials included low birth weight infants, but only one trial enrolled infants on the basis of low birth weight ( ≤ 1250 g) if the precise gestational age was unclear (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). </p> </section> <section id="CD010239-sec-0074"> <h5 class="title">Interventions</h5> <section id="CD010239-sec-0075"> <h6 class="title">Oxygen concentrations</h6> <p>A single study compared air (21% oxygen) with ≥ 40% to 60% (high) oxygen for resuscitation (<a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>). Five studies compared air with 100% oxygen (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). Five studies compared 30% to 40% oxygen with ≥ 60% to 100% (very high) oxygen: one compared 30% oxygen versus 60% oxygen (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>); another compared 30% oxygen versus 100% oxygen (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>); two studies compared 30% oxygen versus 90% oxygen (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>); and one study compared 30% oxygen versus 65% oxygen (<a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). </p> </section> <section id="CD010239-sec-0076"> <h6 class="title">Oxygen targeting</h6> <p>Oxygen saturation targeting criteria and timing varied among the included studies. In all ten studies, supplemental oxygen was adjusted to maintain the oxygen saturation (SpO<sub>2</sub>) above a prespecified lower limit. A lower limit of oxygen saturation target range &lt; 85% was applied in five studies (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). A lower limit of oxygen saturation target range 85% to 90% was applied in eight studies (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> <p>In seven studies (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>), supplemental oxygen was adjusted to maintain the oxygen saturation below a prespecified upper limit in the first 10 minutes of life. Three studies did not prespecify an upper limit (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>). An upper limit of oxygen saturation target range 85% to 90% was applied in two studies (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). An upper limit of oxygen saturation target range &gt; 91% to 95% was applied in six studies (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> <p>Two studies reported oxygen targeting to different SpO<sub>2</sub> ranges between lower and higher oxygen groups. One study, which compared 21% oxygen versus 100% oxygen, reported using interquartile values for healthy newborns for the lower limit in the low oxygen group and a lower limit of 85% in the high oxygen group (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>). The other study prespecified a lower limit of 80% to 85% at five minutes, then 85% to 90% after seven minutes, and an upper limit of ≤ 95% for the high oxygen group (<a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> </section> <section id="CD010239-sec-0077"> <h6 class="title">Type of oximeter</h6> <p>Seven studies used functional oximeters: two studies used Masimo Radical (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>); four studies used Masimo Radical 7 Signal Extraction Technology (<a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>); and one study used Nellcor Oximax‐N‐600x (<a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). Three studies did not describe the type of pulse oximeter used (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>). No studies reported using the most recent model fractional or 'rainbow technology Co‐oximeters' described by Masimo. </p> </section> </section> <section id="CD010239-sec-0078"> <h5 class="title">Outcomes</h5> <p>See <a href="./references#CD010239-sec-0264" title="">Characteristics of included studies</a> for details of outcome reporting for each study. </p> <section id="CD010239-sec-0079"> <h6 class="title">Primary Outcomes</h6> <p>All ten studies reported mortality. Timing of reporting varied; five studies reported mortality before hospital discharge (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>), four studies reported neonatal mortality &lt; 28 days from birth (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016;</a><a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>), two studies reported mortality at an unspecified period (<a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>), one study reported mortality in early infancy (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>), and one study reported late mortality after 18 months postnatal age (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>). Other primary outcomes were less commonly reported. Three studies reported neurodevelopmental disability after 18 months postnatal age <i>(</i><a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). Two studies provided combined data for this outcome (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). The data were calculated separately for each study in this review and recombined in meta‐analysis. One study reported no difference in neuro sensorial dysfunction, but no data were provided (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>). One study is yet to report the planned primary outcome of combined mortality or major disability (or both) at 18 to 24 months corrected age (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). </p> </section> <section id="CD010239-sec-0080"> <h6 class="title">Secondary outcomes</h6> <p>These were all incompletely reported. More commonly reported outcomes included intermittent positive pressure ventilation (IPPV) in the delivery room (five studies); intubation in the delivery room (eight studies), duration of respiratory support (seven studies), severe intraventricular haemorrhage (five studies), necrotising enterocolitis (six studies), and chronic lung disease (requiring oxygen at 36 weeks' postmenstrual age) (nine studies). Outcomes reported by a minority of studies included any retinopathy of prematurity (three studies), severe retinopathy of prematurity (four studies), duration of supplemental oxygen administration (three studies), all intraventricular haemorrhage (four studies), periventricular leukomalacia (three studies), late mortality at &gt; 18 months (two studies), postnatal growth failure (weight &lt; 10th percentile at discharge) (one study), and chronic lung disease (requiring oxygen at 28 postnatal days) (two studies). Duration of respiratory support was variably reported. Four studies reported separate data for duration of mechanical ventilation and duration of continuous positive airway pressure (CPAP) (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>), whilst two studies reported on duration of mechanical ventilation only (<a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). One study included both mechanical ventilation and CPAP in their definition of respiratory support (<a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>), and one combined mechanical ventilation, CPAP, high‐ and low‐flow nasal cannula (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). </p> <p>Several continuous outcomes were reported as non‐parametric data requiring conversion to parametric data for inclusion in analyses. For duration of respiratory support, three studies reported median and interquartile range (IQR) (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>), and three reported median and range (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>). Two studies reported time taken to reach the desired oxygen saturation target (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>), with <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a> reporting median and IQR. Three studies reported on the post hoc outcome 'time taken to reach a heart rate &gt; 100 bpm (minutes)' (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>), with <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a> reporting median and IQR. For duration of supplemental oxygen administration (days from birth), one study reported the data as mean and standard deviation (SD) (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>), whilst two studies reported median and IQR (<a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>). Three studies reported duration of hospitalisation (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>), with two studies reporting data as median and range (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>). </p> </section> </section> </section> <section id="CD010239-sec-0081"> <h4 class="title">Excluded studies</h4> <p>We categorised 12 studies as excluded studies (<a href="./references#CD010239-bbs2-0011" title="BajajN , UdaniRH , NanavatiRN . Room air vs. 100 per cent oxygen for neonatal resuscitation: a controlled clinical trial. Journal of Tropical Pediatrics2005;51(4):206‐11. [DOI: 10.1093/tropej/fmh086; PUBMED: 15927951] ">Bajaj 2005</a>; <a href="./references#CD010239-bbs2-0012" title="DawsonJA , KamlinCO , WongC , tePasAB , O'DonnellCF , DonathSM , et al. Oxygen saturation and heart rate during delivery room resuscitation of infants &lt;30 weeks' gestation with air or 100% oxygen. Archives of Disease in Childhood. Fetal and Neonatal Edition2009;94(2):F87‐91. [DOI: 10.1136/adc.2008.141341; PUBMED: 18703572] ">Dawson 2009</a>; <a href="./references#CD010239-bbs2-0013" title="EzakiS , SuzukiK , KurishimaC , MiuraM , WeilinW , HoshiR , et al. Resuscitation of preterm infants with reduced oxygen results in less oxidative stress than resuscitation with 100% oxygen. Journal of Clinical Biochemistry and Nutrition2009;44(1):111‐8. [DOI: 10.3164/jcbn.08‐221; PUBMED: 19177196] ">Ezaki 2009</a>; <a href="./references#CD010239-bbs2-0014" title="GandhiB , RichW , FinerN . Achieving targeted pulse oximetry values in preterm infants in the delivery room. Journal of Pediatrics2013;163(2):412‐5. [DOI: 10.1016/j.jpeds.2013.01.010; PUBMED: 23415613] ">Gandhi 2013</a>; <a href="./references#CD010239-bbs2-0015" title="HarlingAE , BeresfordMW , VinceGS , BatesM , YoxallCW . Does the use of 50% oxygen at birth in preterm infants reduce lung injury?. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F401‐5. [DOI: 10.1136/adc.2004.059287; PUBMED: 15863491] ">Harling 2005</a>; <a href="./references#CD010239-bbs2-0016" title="LundstromKE , PrydsO , GreisenG . Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Archives of Disease in Childhood1995;73(2):F81‐6. [PUBMED: 7583611] ">Lundstrom 1995</a>; <a href="./references#CD010239-bbs2-0017" title="PopeA , LeoneT , RichW , FinerN . Resuscitation interventions for preterm neonates comparing 21% to 40% oxygen. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.46] ">Pope 2013</a>; <a href="./references#CD010239-bbs2-0018" title="RamjiS , AhujaS , ThirupuramS , RootweltT , RoothG , SaugstadOD . Resuscitation of asphyxic newborn infants with room air or 100% oxygen. Pediatric Research1993;34(6):809‐12. [DOI: 10.1203/00006450‐199312000‐00023] ">Ramji 1993</a>; <a href="./references#CD010239-bbs2-0019" title="RamjiS , RasailyR , MishraPK , NarangA , JayamS , KapoorAN , et al. Resuscitation of asphyxiated newborns with room air or 100% oxygen at birth: a multicentric clinical trial. Indian Pediatrics2003;40(6):510‐7. [PUBMED: 12824660] ">Ramji 2003</a>; <a href="./references#CD010239-bbs2-0020" title="SaugstadOD , RamjiS , IraniSF , El‐MenezaS , HernandezEA , VentoM , et al. Resuscitation of newborn infants with 21% or 100% oxygen: follow‐up at 18 to 24 months. Pediatrics2003;112(2):296‐300. [PUBMED: 12897277] SaugstadOD , RootweltT , AalenO . Resuscitation of asphyxiated newborn infants with room air or oxygen: an international controlled trial: the Resair 2 study. Pediatrics1998;102(1):e1. [PUBMED: 9651453] ">Saugstad 1998</a>; <a href="./references#CD010239-bbs2-0021" title="TomaA , SarbuA , PopescuO , MituR , DobrescuM . Room air versus oxygen in resuscitation of term infants. Pediatric Academic Societies Abstract Archive 2002‐2015. 2006:2860.201. [E‐PAS2006:59:2860.201] Toma , Ai AlbuDF , MituR , MatuE . Follow up for 12 to 15 months of children resuscitated at delivery with 21% or 100% oxygen. Pediatric Academic Societies Abstract Archive 2002‐2015. 2007:8315.5. [E‐PAS2007:618315.5] ">Toma 2006</a>; <a href="./references#CD010239-bbs2-0022" title="TomaA , AlbuDF , DambeanuIM , ConstantinescuA , NaneaM , SchienerM , et al. 21% Oxygen versus 100% oxygen in the resuscitation of term infants. 48th Annual Meeting of the European Society for Paediatric Research. Prague: Acta Paediatrica, 2007; Vol. 96:196. [DOI: 10.1111/j.1651‐2227.2007.00463.x] ">Toma 2007b</a>). See <a href="./references#CD010239-sec-0265" title="">Characteristics of excluded studies</a> for reasons for exclusion. </p> <section id="CD010239-sec-0082"> <h5 class="title">Ongoing studies</h5> <p>We are awaiting data following completion of <a href="./references#CD010239-bbs2-0024" title="NCT01773746 . Study of room air versus 60% oxygen for resuscitation of premature infants (PRESOX) [The premature infants resuscitated with oxygen or air (PRESOX) trial]. ClinicalTrials.gov identifier: NCT01773746 (first received 10 January 2013). ">NCT01773746</a>. Refer to <a href="./references#CD010239-bbs1-0004" title="">Ongoing studies</a> for details. </p> </section> <section id="CD010239-sec-0083"> <h5 class="title">Studies awaiting classification</h5> <p>We are awaiting an English language translation of <a href="./references#CD010239-bbs2-0022" title="TomaA , AlbuDF , DambeanuIM , ConstantinescuA , NaneaM , SchienerM , et al. 21% Oxygen versus 100% oxygen in the resuscitation of term infants. 48th Annual Meeting of the European Society for Paediatric Research. Prague: Acta Paediatrica, 2007; Vol. 96:196. [DOI: 10.1111/j.1651‐2227.2007.00463.x] ">Toma 2007b</a>. Refer to <a href="./references#CD010239-bbs1-0003" title="">Studies awaiting classification</a> for details. </p> </section> </section> </section> <section id="CD010239-sec-0084"> <h3 class="title">Risk of bias in included studies</h3> <p>See 'Risk of bias' graph (<a href="#CD010239-fig-0002">Figure 2</a>) and 'Risk of bias' summary (<a href="#CD010239-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD010239-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010239-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD010239-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010239-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010239-sec-0085"> <h4 class="title">Allocation</h4> <p>We assessed three studies as having unclear risk of selection bias as they did not report the method of sequence generation (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). We assessed one study, <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>, as having high risk of bias due to lack of allocation concealment as they allowed consent to be obtained from parents after the intervention. Two studies were at unclear risk of selection bias due to lack of reporting of allocation concealment (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>). We judged six studies as having low risk of selection bias overall (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>), three studies as having unclear risk of bias (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>), and one as having high risk of bias (<a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>). </p> <p>Studies at unclear or high risk of selection bias have a relatively low weight in analyses of mortality (10.1%)<i>;</i> intubation in the delivery room (15.4%); severe retinopathy of prematurity (7.7%); severe intraventricular haemorrhage (2.3%); necrotising enterocolitis (24.7%); and chronic lung disease at 36 weeks (22.8%). Neurodevelopmental disability was reported by a single study assessed as being at low risk of selection bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>). </p> </section> <section id="CD010239-sec-0086"> <h4 class="title">Blinding</h4> <p>Six studies did not report blinding of participants or personnel (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>), and in one study the blinding was unclear (<a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>). One study, <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>, reported not blinding outcome assessment; and blinding was unclear in five (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). Three studies reported adequate blinding of participants, personnel and outcome assessment and we judged these to have low risk of performance and detection bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). </p> <p>Studies at high or unclear risk of performance and detection bias were heavily weighted in analyses of mortality; intubation in the delivery room; severe retinopathy of prematurity; severe intraventricular haemorrhage; necrotising enterocolitis; and chronic lung disease. Neurodevelopmental disability was reported by two studies assessed as having low risk of performance and detection bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>)<b>.</b> Outcomes such as intubation in the delivery room were likely to be at highest risk of bias from lack of blinding of personnel. </p> </section> <section id="CD010239-sec-0087"> <h4 class="title">Incomplete outcome data</h4> <p>Four studies were at unclear risk of attrition bias, including: <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a> (losses not reported); <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a> (losses not reported); <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a> (unclear if 103 infants (49%) were excluded pre‐ or post‐randomisation); and <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a> (18% of infants not resuscitated so 'lost to randomisation'; 2 infants not accounted for and 7 infants who died were not reported for other outcomes). We judged six studies to have low risk of attrition bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> <p>Studies that were at high or unclear risk of attrition bias have low to moderate weight in analyses of mortality (21.5%); intubation in the delivery room (39.3%); severe intraventricular haemorrhage (43.7%)<i>;</i> necrotising enterocolitis (30%); and chronic lung disease (27.3%). Neurodevelopmental disability was reported by two studies assessed as having low risk of attrition bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>); and severe retinopathy of prematurity was reported by four studies which had low risk of bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). </p> </section> <section id="CD010239-sec-0088"> <h4 class="title">Selective reporting</h4> <p>Eight studies were at unclear risk of reporting bias predominantly due to lack of protocol availability (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). We assessed three studies as having low risk of reporting bias (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> </section> <section id="CD010239-sec-0089"> <h4 class="title">Other potential sources of bias</h4> <p>We considered one study to have a substantial baseline difference between groups (breech presentation) (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>); and we assessed three studies as having unclear risk of bias due to some baseline differences or failure to adequately report baseline characteristics (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> </section> </section> <section id="CD010239-sec-0090"> <h3 class="title" id="CD010239-sec-0090">Effects of interventions</h3> <p>See: <a href="./full#CD010239-tbl-0001"><b>Summary of findings for the main comparison</b> Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth</a> </p> <section id="CD010239-sec-0091"> <h4 class="title">Comparison 1. Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations </h4> <p>Ten studies (962 infants) compared lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>; <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). </p> <section id="CD010239-sec-0092"> <h5 class="title">Primary Outcomes</h5> <section id="CD010239-sec-0093"> <h6 class="title">Mortality, near term corrected or discharge (latest reported) (Analysis 1.1)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (risk ratio (RR) 1.05, 95% CI 0.68 to 1.63; participants = 914; studies = 10; I<sup>2</sup> = 11%). We graded the quality of evidence as low, due to risk of bias and imprecision of the estimate. </p> </section> <section id="CD010239-sec-0094"> <h6 class="title">Neurodevelopmental disability (Analysis 1.2)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.82, 95% CI 0.49 to 1.35; participants = 208; studies = 2; I<sup>2</sup> = 53%). We identified moderate heterogeneity in this analysis. </p> </section> </section> <section id="CD010239-sec-0095"> <h5 class="title">Secondary Outcomes</h5> <section id="CD010239-sec-0096"> <h6 class="title">Intermittent positive pressure ventilation (IPPV) in the delivery room (Analysis 1.3)</h6> <p>Our meta‐analysis showed no significant difference in need for IPPV in the delivery room between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.94, 95% CI 0.83 to 1.06; participants = 249; studies = 5; I<sup>2</sup> = 13%). </p> </section> <section id="CD010239-sec-0097"> <h6 class="title">Intubation in the delivery room (Analysis 1.4)</h6> <p>Our meta‐analysis showed no significant difference in the need for intubation in the delivery room between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.98, 95% CI 0.82 to 1.18; participants = 875; studies = 9; I<sup>2</sup> = 0%). We graded the quality of evidence as low, due to risk of bias and imprecision of the estimate. </p> </section> <section id="CD010239-sec-0098"> <h6 class="title">Time to reach desired oxygen saturation target (Analysis 1.5)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (MD ‐0.52 minutes, 95% CI ‐1.83 to 0.79; participants = 102; studies = 2; I<sup>2</sup> = 85%). </p> </section> <section id="CD010239-sec-0099"> <h6 class="title">Time to reach heart rate &gt; 100 beats per minute (not prespecified) (Analysis 1.6)</h6> <p>One study, <a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>, reported no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (MD 0.27 minutes, 95% CI ‐1.21 to 1.75; participants = 60; I<sup>2</sup> = 0%). One of the studies, <a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>, reported data as median/interquartile range (IQR) and included additional criteria for time to response (SpO<sub>2</sub> &gt; 85% and good response to stimuli) so data from this study were not included in meta‐analysis This outcome is reported post hoc. </p> </section> <section id="CD010239-sec-0100"> <h6 class="title">Retinopathy of prematurity (any) (Analysis 1.7)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.80, 95% CI 0.43 to 1.49; participants = 373; studies = 4; I<sup>2</sup> = 0%). </p> </section> <section id="CD010239-sec-0101"> <h6 class="title">Severe retinopathy of prematurity (≥ stage 3) (Analysis 1.8)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.57, 95% CI 0.24 to 1.36; participants = 453; studies = 4; I<sup>2</sup> = 0%). We graded the quality of evidence as low, due to risk of bias and imprecision of the estimate. </p> </section> <section id="CD010239-sec-0102"> <h6 class="title">Intraventricular haemorrhage (IVH) (any) (Analysis 1.9)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.81, 95% CI 0.46 to 1.44; participants = 271; studies = 3; I<sup>2</sup> = 0%). </p> </section> <section id="CD010239-sec-0103"> <h6 class="title">Severe intraventricular haemorrhage (IVH) (grade 3 or 4) (Analysis 1.10)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.93, 95% CI 0.51 to 1.71; participants = 596; studies = 6; I<sup>2</sup> = 0%). No individual study reported a significant effect. We graded the quality of evidence as low, due to risk of bias and imprecision of the estimate. </p> </section> <section id="CD010239-sec-0104"> <h6 class="title">Periventricular leukomalacia (PVL) (Analysis 1.11)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen group (RR 0.66, 95% CI 0.09 to 4.73; participants = 130; studies = 2; I<sup>2</sup> = 0%). </p> </section> <section id="CD010239-sec-0105"> <h6 class="title">Hypoxic ischaemic encephalopathy</h6> <p>Not reported by any trial.</p> </section> <section id="CD010239-sec-0106"> <h6 class="title">Necrotising enterocolitis (proven) (Analysis 1.12)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.98, 95% CI 0.51 to 1.87; participants = 807; studies = 8; I<sup>2</sup> = 1%). We graded the quality of evidence as low, due to risk of bias and imprecision of the estimate. </p> </section> <section id="CD010239-sec-0107"> <h6 class="title">Chronic lung disease (28 days) (Analysis 1.13)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.70, 95% CI 0.41 to 1.21; participants = 148; studies = 2; I<sup>2</sup> = 66%). We identified moderate heterogeneity in this analysis. </p> </section> <section id="CD010239-sec-0108"> <h6 class="title">Chronic lung disease (36 weeks) (Analysis 1.14)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.91, 95% CI 0.72 to 1.14; participants = 862; studies = 9; I<sup>2</sup> = 45%). We identified mimimal heterogeneity in this analysis. We graded the quality of evidence as low, due to risk of bias of included studies, lack of precision of the estimate and heterogeneity between studies detected in the analysis. </p> </section> <section id="CD010239-sec-0109"> <h6 class="title">Duration of respiratory support (mechanical ventilation or CPAP ) (days from birth) (Analysis 1.15) </h6> <p>Our meta‐analysis showed infants who received lower (FiO<sub>2</sub> &lt; 0.4) oxygen had a shorter duration of respiratory support (mechanical ventilation or CPAP<i>)</i> compared to infants on higher oxygen (FiO<sub>2</sub> ≥ 0.4) (MD ‐12.39, 95% CI ‐13.49 to ‐11.29; participants = 326; studies = 2; I<sup>2</sup> = 98%). We identified high heterogeneity in this analysis. </p> </section> <section id="CD010239-sec-0110"> <h6 class="title">Duration of respiratory support (mechanical ventilation) (days from birth) (Analysis 1.16) </h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (MD 0.61, 95% CI ‐1.33 to 2.54; participants = 510; studies = 6; I<sup>2</sup> = 0%). This outcome was included post hoc. </p> </section> <section id="CD010239-sec-0111"> <h6 class="title">Duration of respiratory support (continuous positive airway pressure (CPAP)) (days from birth) (Analysis 1.17) </h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (MD ‐1.60, 95% CI ‐5.39 to 2.19; participants = 249; studies = 4; I<sup>2</sup> = 0%) This outcome was included post hoc. </p> </section> <section id="CD010239-sec-0112"> <h6 class="title">Duration of supplemental oxygen administration (days) (Analysis 1.18)</h6> <p>Our meta‐analysis showed infants allocated to the lower oxygen group (FiO<sub>2</sub> &lt; 0.4) had a shorter duration of supplemental oxygen administration compared to infants allocated to the higher oxygen (FiO<sub>2</sub> ≥ 0.4) group (MD 9.23 days, 95% CI 6.52 to 11.95; participants = 639; studies = 5; I<sup>2</sup> = 79%). We identified high heterogeneity in this analysis. </p> </section> <section id="CD010239-sec-0113"> <h6 class="title">Mortality to follow‐up (&gt; 18 months) (Analysis 1.19)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 1.00, 95% CI 0.59 to 1.70; participants = 540; studies = 3; I<sup>2</sup> = 65%). </p> </section> <section id="CD010239-sec-0114"> <h6 class="title">Postnatal growth failure (weight &lt; 10th percentile at discharge) (Analysis 1.20)</h6> <p>One study, <a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>, reported no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.86, 95% CI 0.55 to 1.33; participants = 60). </p> </section> <section id="CD010239-sec-0115"> <h6 class="title">Duration of hospitalisation (days) (Analysis 1.21)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (MD ‐1.75, 95% CI ‐12.22 to 8.71; participants = 216; studies = 3; I<sup>2</sup> = 33%). </p> </section> <section id="CD010239-sec-0116"> <h6 class="title">Patent ductus arteriosus (not prespecified) (Analysis 1.22)</h6> <p>Our meta‐analysis showed no significant difference between lower (FiO<sub>2</sub> &lt; 0.4) or higher (FiO<sub>2</sub> ≥ 0.4) oxygen groups (RR 0.93, 95% CI 0.77 to 1.14; participants = 766; studies = 7; I<sup>2</sup> = 0%). </p> </section> </section> </section> <section id="CD010239-sec-0117"> <h4 class="title">Subgroup analyses (Appendix 3)</h4> <p>The following subgroup comparisons are appended in <a href="./appendices#CD010239-sec-0135">Appendix 3</a>: </p> <p>Comparison 2. Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations subgrouped by FiO<sub>2</sub> </p> <p>Comparison 3. Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation target range at 5 to 10 minutes </p> <p>Comparison 4. Lower versus higher oxygen concentrations — subgrouped by higher limit of oxygen saturation target range at 5 to 10 minutes </p> <p>Comparison 5. Lower versus higher oxygen concentrations — subgrouped by gestational age </p> <p>Comparison 6. Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration — sensitivity analysis </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010239-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010239-sec-0118"></div> <section id="CD010239-sec-0119"> <h3 class="title" id="CD010239-sec-0119">Summary of main results</h3> <section id="CD010239-sec-0120"> <h4 class="title">Mortality and neurodevelopment</h4> <p>Overall, our meta‐analysis of 10 studies (with a total of 914 infants) showed no difference in mortality to discharge. We downgraded our assessment of the quality of evidence to low, due to risk of bias and imprecision. We found no subgroup differences according to inspired oxygen concentration strata. However we did find a significant subgroup difference in mortality according to lower limit of oxygen saturation target range at 5 to 10 minutes' age. A single study targeting lowest oxygen saturation (SpO<sub>2</sub>) &lt; 85% reported increased mortality for infants resuscitated with air compared to those resuscitated with 100% oxygen (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>), whereas meta‐analysis of nine studies (627 infants) targeting lowest SpO<sub>2</sub> 85% to 90% showed no difference in mortality. We found no subgroup differences according to higher limit of SpO<sub>2</sub> target range or gestational age (≤ 28 weeks versus &gt; 28 weeks to 32 weeks<i>)</i>. </p> <p>Meta‐analysis of two studies (208 infants) showed no difference in neurodevelopmental disability at 18 to 24 months of age. Both studies compared fractional inspired oxygen (FiO<sub>2</sub>) ≥ 0.3 to &lt; 0.4 versus FiO<sub>2</sub> ≥ 0.6 to 0.65 and had a lowest SpO<sub>2</sub> target of 85% to 90%. We assessed the quality of evidence as low, due to inconsistency and imprecision. </p> </section> <section id="CD010239-sec-0121"> <h4 class="title">Response to resuscitation</h4> <p>We found no overall difference in use of intermittent positive pressure ventilation or intubation in the delivery room for infants receiving lower versus higher oxygen concentrations. For intubation, subgroup analyses showed no differences between groups according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. We downgraded our assessment of the quality of evidence to low, due to risk of bias and imprecision. There were limited data that reported time to reach desired oxygen saturation target or heart rate, with no significant differences identified. </p> </section> <section id="CD010239-sec-0122"> <h4 class="title">Neonatal outcomes</h4> <p>We found no difference between use of lower versus higher concentrations of oxygen for the following outcomes: any retinopathy, severe retinopathy (low‐quality evidence), any intraventricular haemorrhage (IVH), severe IVH (low‐quality evidence), periventricular leukomalacia, necrotising enterocolitis (low‐quality evidence), chronic lung disease at 28 days or 36 weeks' gestation (very low‐quality evidence), postnatal growth failure, duration of hospitalisation, or patent ductus arteriosus. There were also no significant subgroup differences for these neonatal outcomes according to inspired oxygen concentration strata, lowest SpO<sub>2</sub> target, highest SpO<sub>2</sub> target, and gestational age strata (≤ 28 weeks versus &gt; 28 weeks to 32 weeks). </p> <p>Studies reported duration of respiratory support as various combinations of mechanical ventilation, continuous positive airway pressure (CPAP), and high‐flow nasal cannula (HFNC). This resulted in difficulty pooling data. For our prespecified outcome, duration of positive pressure respiratory support (mechanical ventilation or CPAP), there was a mean reduction of 12.4 days (95% CI 11.3 to 13.5 days) through use of lower versus higher oxygen concentration, though this was only reported by a minority of studies (two studies, 326 infants). For outcomes that were not prespecified by this review, we found no difference in duration of mechanical ventilation (which was reported by six studies including 510 infants) or duration of CPAP (which was reported by four studies including 249 infants). There was an mean +9.2 day (95% CI 6.5 to 12.0 day) increase in duration of supplemental oxygen administration, which was reported by five studies including 639 infants. We identified high levels of heterogeneity in the analyses of duration of respiratory support and duration of supplemental oxygen. Subgroup analyses showed a decreased duration of respiratory support (mechanical ventilation or CPAP), but an increased duration of supplemental oxygen, from use of low oxygen concentrations. This was attributable to a single study (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>), which compared inspired oxygen concentrations of 0.21 versus 1.0 and had a lower SpO<sub>2</sub> target &lt; 85% at 5 to 10 minutes. </p> </section> </section> <section id="CD010239-sec-0123"> <h3 class="title" id="CD010239-sec-0123">Overall completeness and applicability of evidence</h3> <p>We included ten trials that reported outcomes for 914 infants in this review. The majority of included infants were of extreme preterm gestation, with subgroup analysis of mortality including 516 infants ≤ 28 weeks' gestation and 316 infants of 28 to 32 weeks' gestation. </p> <p>The trials compared various oxygen concentrations for resuscitation. The common comparisons were air versus 100% oxygen, reported by five studies (<a href="./references#CD010239-bbs2-0004" title="KapadiaVS , ChalakLF , ChristieL , SavaniRC , WyckoffMH . Randomized controlled trial of limited versus traditional oxygen strategy during resuscitation in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:3500.6] KapadiaVS , ChalakLF , SparksJE , AllenJR , SavaniRC , WyckoffMH . Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics2013;132(6):1488‐96. [DOI: 10.1542/peds.2013‐0978; NCT01697904; PUBMED: 24218465] ">Kapadia 2013</a>; <a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>; <a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>; <a href="./references#CD010239-bbs2-0007" title="RabiY , SinghalN , Nettel‐AguirreA . Room‐air versus oxygen administration for resuscitation of preterm infants: The ROAR study. Pediatrics2011;128(2):e374‐81. [DOI: 10.1542/peds.2010‐3130; PUBMED: 21746729] RabiY , SinghalN , TangS , LodhaA . Neurodevelopmental outcomes for preterm infants resuscitated with different oxygen concentrations. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:4525.358] ">Rabi 2011</a>; <a href="./references#CD010239-bbs2-0010" title="WangCL , AndersonC , LeoneTA , RichW , GovindaswamiB , FinerNN . Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics2008;121(6):1083‐9. [DOI: 10.1542/peds.2007‐1460; NCT00369720; PUBMED: 18519476] WangCL , LeoneTA , RichW , FinerNN . Room air or oxygen for resuscitation of preterm, very low birthweight (VLBW) neonates. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2007. [E‐PAS2007:617932.23] ">Wang 2008</a>). A single study compared air with 40% oxygen (<a href="./references#CD010239-bbs2-0005" title="KumarVH , CarrionV , WynnKA , NielsenL , ReynoldsAM , RyanRM . Oxygen resuscitation and oxidative‐stress biomarkers in premature infants. Research and Reports in Neonatology2014;4:91‐9. [DOI: 10.2147/RRN.S62679] KumarVH , WynnK , RyanRM , NielsenL , ReynoldsAM , CarrionV . Randomized trial of varying levels of oxygen (21%, 40% and 100%) at resuscitation in premature infants &lt; 32 wks GA. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2012. [E‐PAS2012:128; E‐PAS2012:4525.352] ">Kumar 2014</a>). Five studies used various supplemental oxygen concentrations in both groups: 30% versus 60% oxygen (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>); 30% oxygen versus 65% oxygen (<a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>); 30% oxygen versus 90% oxygen (<a href="./references#CD010239-bbs2-0003" title="EscrigR , ArruzaL , IzquierdoI , VillarG , SaenzP , GimenoA , et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics2008;121(5):875‐81. [DOI: 10.1542/peds.2007‐1984; NCT00494702; PUBMED: 18450889] ">Escrig 2008</a>; <a href="./references#CD010239-bbs2-0009" title="VentoM , MoroM , EscrigR , VarruzaL , VillarG , IzquierdoI , et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics2009;124(3):e439‐49. [DOI: 10.1542/peds.2009‐0434; PUBMED: 19661049] ">Vento 2009</a>); and 30% oxygen versus 100% oxygen (<a href="./references#CD010239-bbs2-0002" title="ArmanianAM , BadieeZ . Resuscitation of preterm newborns with low concentration oxygen versus high concentration oxygen. Journal of Research in Pharmacy Practice2012;1(1):25‐9. [DOI: 10.4103/2279‐042X.99674; PUBMED: 24991584] BadieeZ , ArmanianAM . Resuscitation of preterm newborn with high concentration oxygen versus low concentration oxygen. Journal of Isfahan Medical School2011;29(145):847‐54. ">Armanian 2012</a>). </p> <p>All trials reported mortality. Although no significant difference was found between lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations overall, the analysis lacks precision so is underpowered to detect an important effect. In addition, a subgroup analysis identified a single study (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>) targeting a lower limit of oxygen saturation range of &lt; 85% that reported increased mortality in the air group compared to the 100% oxygen group. There were no other significant subgroup effects for mortality according to SpO<sub>2</sub> target or gestational strata (≤ 28 weeks or 28 to 32 weeks' gestation). </p> <p>Reporting of other outcomes was variable among trials and not consistently reported in the same manner. Only two trials reported on neurodevelopmental disability in 208 infants. There were no significant differences in long‐term effects of using lower versus higher oxygen concentrations. </p> <p>Among hospital outcomes, intubation in the delivery room was reported by nine trials including 875 infants, with no significant difference between groups found. Other commonly reported outcomes were severe Intraventricular haemorrhage (IVH) (6 studies, 596 infants), necrotising enterocolitis (8 studies, 807 infants) and chronic lung disease at 36 weeks (9 studies, 862 infants). All other prespecified outcomes were reported by a minority of studies. </p> <p>Duration of specific types of respiratory support was reported variably by studies. Only two studies reported our prespecified outcome (mechanical ventilation and CPAP). Duration of mechanical ventilation, duration of CPAP and duration of supplemental oxygen were more commonly reported. There was a high level of heterogeneity between studies of the effect of differing oxygen concentrations on duration of respiratory support (mechanical ventilation and CPAP) in the meta‐analysis. A high level of heterogeneity was also present in the analysis of duration of supplemental oxygen administration. A single study reported a reduction in duration of respiratory support (mechanical ventilation and CPAP) but an increase in duration of supplemental oxygen (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). No difference was found in analyses of duration of mechanical ventilation or duration of CPAP, or chronic lung disease at 36 weeks. As effects on duration of respiratory support and duration of supplemental oxygen administration are largely limited to a single study, the results should be treated with caution. </p> </section> <section id="CD010239-sec-0124"> <h3 class="title" id="CD010239-sec-0124">Quality of the evidence</h3> <p>We graded the quality of the evidence as 'low' or 'very low' for all prespecified GRADE rated outcomes. We downgraded our assessment of the quality of evidence for mortality to discharge as only two of 10 studies were at low risk of bias and had sufficiently precise estimates. Common methodological concerns were unclear or high risk of selection bias (four studies) and lack of blinding of intervention (five studies). Two studies reported neurodevelopment in 208 infants; we downgraded our assessment of the quality of this evidence due to inconsistency (moderate heterogeneity, I<sup>2</sup> = 53%) and imprecision. There was also inconsistency (high heterogeneity, I<sup>2</sup> &gt; 75%) in analyses of duration of respiratory support (mechanical ventilation and CPAP) and duration of supplemental oxygen. Subgroup analyses identified the heterogeneity could be due to differences between studies in inspired oxygen concentrations, or differences in the lowest SpO<sub>2</sub> target ranges (or both). Two studies, which reported outcomes of 253 infants, were at low risk of bias and were included in sensitivity analyses (<a href="./references#CD010239-bbs2-0001" title="AguarM , BrugadaM , EscobarJ , CubellsE , KuligowskiJ , CernadaM , et al. Resuscitation of ELBW infants with initial FiO2 of 30% vs. 60%, a randomized, controlled, blinded study: the REOX trial. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2013. [E‐PAS2013:4501.55] AguarM , CubellsE , EscobarJ , KuligowskiJ , IriondoM , IzquierdoM , et al. Preterm babies randomly assigned to be blindly resuscitated with higher (60%) vs. lower (30%) initial FIO2: effects on oxidative stress and mortality. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2014. [E‐PAS2014:3843.540] BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] Vento TorresM , AguarM , IzquierdoM , BrugadaM , IriondoM , EscobarJ , et al. Higher (60%) vs. lower (30%) initial oxygen inspiratory fraction for ventilation of preterm infants in the delivery room: a randomised, double blinded, pilot study. ESPR 54th Annual Conference. 2013:155. ">Aguar 2013</a>; <a href="./references#CD010239-bbs2-0008" title="BoronatN , AguarM , RookD , IriondoM , BrugadaM , CernadaM , et al. Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions. Pediatrics2016;138(6):e20161405. [DOI: 10.1542/peds.2016‐1405; PUBMED: 27940687] RookD , SchierbeekH , VentoM , VlaardingerbroekH , van derEijkAC , LonginiM , et al. Resuscitation of preterm infants with different inspired oxygen fractions. Journal of Pediatrics2014;164(6):1322‐6. [DOI: 10.1016/j.jpeds.2014.02.019; PUBMED: 24655537] RookD , SchierbeekH , van derEijkAC , LonginiM , BuonocoreG , VentoM , et al. Resuscitation of very preterm infants with 30% vs 65% oxygen at birth: study protocol for a randomized controlled trial. Trials2012;13:65. [DOI: 10.1186/1745‐6215‐13‐65] RookD , VlaardingerbroekH , SchierbeekH , Van DerEijkAC , EscobarJ , LonginiM , et al. A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth. Archives of Disease in Childhood2012;97(Suppl 2):A113. ">Rook 2014</a>). The studies reported no significant differences in mortality to discharge, neurodevelopmental disability, outcomes relating to response to resuscitation and multiple neonatal morbidities. Given the findings of the sensitivity analyses, it is possible observed differences between lower and high oxygen concentration groups in specific analyses were due to bias. </p> </section> <section id="CD010239-sec-0125"> <h3 class="title" id="CD010239-sec-0125">Potential biases in the review process</h3> <p>In this review we prespecified inclusion criteria, performed an extensive search of the literature (supplemented by searches of conference abstracts and expert informants), independently and reproducibly assessed eligibility, assessed risk of bias, extracted data and graded the quality of evidence. We resolved differences by discussion. There were difficulties in extracting data for prespecified respiratory support outcomes, duration of respiratory support, duration of supplemental oxygen and duration of hospitalisation, as the reporting in the majority of trials was not compatible. Data were variably reported as means (standard deviation (SD)), median and range or interquartile range. We converted non‐parametric data to mean (SD) for inclusion in analyses. These data should be treated with caution as means (SD) were estimated and could be affected by data skew. </p> </section> <section id="CD010239-sec-0126"> <h3 class="title" id="CD010239-sec-0126">Agreements and disagreements with other studies or reviews</h3> <p>An earlier systematic review of randomised controlled trials, by Brown and colleagues (<a href="./references#CD010239-bbs2-0027" title="BrownJV , Moe‐ByrneT , HardenM , McGuireW . Lower versus higher oxygen concentration for delivery room stabilisation of preterm neonates: systematic review. PLoS ONE2012; Vol. 7, issue 12:e52033. [DOI: 10.1371/journal.pone.0052033; PUBMED: 23284861] ">Brown 2012b</a>), assessed the effect of lower (FiO<sub>2</sub> 21% to 50%) versus higher (FiO<sub>2</sub> &gt; 50%) oxygen concentrations for delivery room support of preterm infants. Six trials enrolling 484 infants were identified. Most participants were born before 32 weeks' gestation. Meta‐analyses showed a significant reduction in death (RR 0.65, 95% CI 0.43 to 0.98). However, no effect was found when analysis was limited to the four trials with adequate allocation concealment (RR 1.0, 95% CI 0.45 to 2.24). </p> <p>A recent systematic review of infants born ≤ 28 weeks and six days' gestation randomised to resuscitation with low (FiO<sub>2</sub> ≤ 0.3) versus high (FiO<sub>2</sub> ≥ 0.6) oxygen at delivery identified 504 infants enrolled in eight studies (<a href="./references#CD010239-bbs2-0044" title="OeiJL , VentoM , RabiY , WrightI , FinerN , RichW , et al. Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: a meta‐analysis. Archives of Disease in Childhood. Fetal and Neonatal Edition2017;102(1):F24‐30. [DOI: 10.1136/archdischild‐2016‐310435; PUBMED: 27150977] ">Oei 2017</a>). Meta‐analyses found no difference in bronchopulmonary dysplasia (RR 0.88, 95% CI 0.68 to 1.14), intraventricular haemorrhage (RR 0.81, 95% CI 0.52 to 1.27), retinopathy of prematurity (RR 0.82, 95% CI 0.46 to 1.46), patent ductus arteriosus (RR 0.95, 95% CI 0.80 to 1.14) and necrotising enterocolitis (RR 1.61, 95% CI 0.67 to 3.36) and overall mortality (RR 0.99, 95% CI 0.52 to 1.91). The review reported mortality was lower in low oxygen arms of masked studies (RR 0.46, 95% CI 0.23 to 0.92; P = 0.03) and higher in low oxygen arms of unmasked studies (RR 1.94 95% CI 1.02 to 3.68, P = 0.04). </p> <p>This review has been cross‐checked against <a href="./references#CD010239-bbs2-0044" title="OeiJL , VentoM , RabiY , WrightI , FinerN , RichW , et al. Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: a meta‐analysis. Archives of Disease in Childhood. Fetal and Neonatal Edition2017;102(1):F24‐30. [DOI: 10.1136/archdischild‐2016‐310435; PUBMED: 27150977] ">Oei 2017</a>, for data accuracy. The conclusion of the review by Oei and colleagues was a finding of no difference in risk of death or other morbidity after resuscitation is initiated at delivery with lower (≤ 0.3) or higher (≥ 0.6) oxygen concentrations (<a href="./references#CD010239-bbs2-0044" title="OeiJL , VentoM , RabiY , WrightI , FinerN , RichW , et al. Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: a meta‐analysis. Archives of Disease in Childhood. Fetal and Neonatal Edition2017;102(1):F24‐30. [DOI: 10.1136/archdischild‐2016‐310435; PUBMED: 27150977] ">Oei 2017</a>). The need for larger, well designed studies was identified. </p> <p>A recent systematic review of RCTs that enrolled babies born &lt; 28 weeks’ gestation, at birth or soon thereafter, and targeted SpO<sub>2</sub> ranges of either ≤ 90% or &gt; 90% found targeting lower compared to higher SpO<sub>2</sub> had no significant effect on the composite outcome of death or major disability or on major disability alone, but increased the average risk of mortality by 28 per 1000 infants treated (<a href="./references#CD010239-bbs2-0025" title="AskieLM , DarlowBA , DavisPG , FinerN , StensonB , VentoM , et al. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 4. [DOI: 10.1002/14651858.CD011190.pub2] ">Askie 2017</a>). However, the findings are not directly applicable to resuscitation, since three trials enrolled infants &lt; 24 hours' age, one trial infants &lt; 12 hours' age and one trial required infants to be enrolled by 2 hours of age. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010239-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010239-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010239-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010239-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration." data-id="CD010239-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 2 Neurodevelopmental disability." data-id="CD010239-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 2 Neurodevelopmental disability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 3 IPPV in the delivery room." data-id="CD010239-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 3 IPPV in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 4 Intubation in the delivery room." data-id="CD010239-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 4 Intubation in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 5 Time to reach desired oxygen saturation target." data-id="CD010239-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 5 Time to reach desired oxygen saturation target. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified)." data-id="CD010239-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 7 Retinopathy of prematurity." data-id="CD010239-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 7 Retinopathy of prematurity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 8 Severe retinopathy of prematurity (≥ stage 3)." data-id="CD010239-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 8 Severe retinopathy of prematurity (≥ stage 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 9 Intraventricular haemorrhage." data-id="CD010239-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 9 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4)." data-id="CD010239-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 11 Periventricular leukomalacia." data-id="CD010239-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 11 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 12 Necrotising enterocolitis." data-id="CD010239-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 12 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 13 Chronic lung disease (28 days' age)." data-id="CD010239-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 13 Chronic lung disease (28 days' age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 14 Chronic lung disease (36 weeks' corrected age)." data-id="CD010239-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 14 Chronic lung disease (36 weeks' corrected age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth)." data-id="CD010239-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth)." data-id="CD010239-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 17 Duration of respiratory support (CPAP) (days from birth)." data-id="CD010239-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 17 Duration of respiratory support (CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 18 Duration of supplemental oxygen administration." data-id="CD010239-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 18 Duration of supplemental oxygen administration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 19 Mortality to follow up (&gt; 18 months)." data-id="CD010239-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 19 Mortality to follow up (&gt; 18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge)." data-id="CD010239-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 21 Duration of hospitalisation (days)." data-id="CD010239-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 21 Duration of hospitalisation (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration, Outcome 22 Patent ductus arteriosus (not prespecified)." data-id="CD010239-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration, Outcome 22 Patent ductus arteriosus (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration." data-id="CD010239-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 2 Neurodevelopmental disability." data-id="CD010239-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 2 Neurodevelopmental disability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 3 IPPV in the delivery room." data-id="CD010239-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 3 IPPV in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 4 Intubation in the delivery room." data-id="CD010239-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 4 Intubation in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 5 Time to reach desired oxygen saturation target." data-id="CD010239-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 5 Time to reach desired oxygen saturation target. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified)." data-id="CD010239-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 7 Retinopathy of prematurity." data-id="CD010239-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 7 Retinopathy of prematurity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 8 Severe retinopathy of prematurity (≥ stage 3)." data-id="CD010239-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 8 Severe retinopathy of prematurity (≥ stage 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 9 Intraventricular haemorrhage." data-id="CD010239-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 9 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4)." data-id="CD010239-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 11 Periventricular leukomalacia." data-id="CD010239-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 11 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 12 Necrotising enterocolitis." data-id="CD010239-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 12 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 13 Chronic lung disease (28 days age)." data-id="CD010239-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 13 Chronic lung disease (28 days age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 14 Chronic lung disease (36 weeks' corrected age)." data-id="CD010239-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 14 Chronic lung disease (36 weeks' corrected age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth)." data-id="CD010239-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth)." data-id="CD010239-fig-0041" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 17 Duration of respiratory support (CPAP) (days from birth)." data-id="CD010239-fig-0042" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 17 Duration of respiratory support (CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 18 Duration of supplemental oxygen administration." data-id="CD010239-fig-0043" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 18 Duration of supplemental oxygen administration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 19 Mortality to follow up (&gt; 18 months)." data-id="CD010239-fig-0044" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 19 Mortality to follow up (&gt; 18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge)." data-id="CD010239-fig-0045" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 21 Duration of hospitalisation (days)." data-id="CD010239-fig-0046" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.21</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 21 Duration of hospitalisation (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-002-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-002-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO2, Outcome 22 Patent ductus arteriosus (not prespecified)." data-id="CD010239-fig-0047" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.22</div> <div class="figure-caption"> <p>Comparison 2 Lower versus higher oxygen concentration subgrouped by FiO<sub>2</sub>, Outcome 22 Patent ductus arteriosus (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-002-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 1 Mortality near term corrected age or discharge (latest reported)." data-id="CD010239-fig-0048" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 1 Mortality near term corrected age or discharge (latest reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 2 Neurodevelopmental disability." data-id="CD010239-fig-0049" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 2 Neurodevelopmental disability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 3 IPPV in the delivery room." data-id="CD010239-fig-0050" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 3 IPPV in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 4 Intubation in the delivery room." data-id="CD010239-fig-0051" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 4 Intubation in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 5 Time to reach desired oxygen saturation target." data-id="CD010239-fig-0052" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 5 Time to reach desired oxygen saturation target. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified)." data-id="CD010239-fig-0053" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 7 Retinopathy of prematurity." data-id="CD010239-fig-0054" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 7 Retinopathy of prematurity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 8 Severe retinopathy of prematurity (≥ stage 3)." data-id="CD010239-fig-0055" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 8 Severe retinopathy of prematurity (≥ stage 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 9 Intraventricular haemorrhage." data-id="CD010239-fig-0056" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 9 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4)." data-id="CD010239-fig-0057" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 11 Periventricular leukomalacia." data-id="CD010239-fig-0058" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 11 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 12 Necrotising enterocolitis." data-id="CD010239-fig-0059" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 12 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 13 Chronic lung disease (28 days' age)." data-id="CD010239-fig-0060" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 13 Chronic lung disease (28 days' age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 14 Chronic lung disease (36 weeks' corrected age)." data-id="CD010239-fig-0061" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 14 Chronic lung disease (36 weeks' corrected age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth)." data-id="CD010239-fig-0062" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth)." data-id="CD010239-fig-0063" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 17 Duration of respiratory support (CPAP) (days from birth)." data-id="CD010239-fig-0064" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 17 Duration of respiratory support (CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 18 Duration of supplemental oxygen administration." data-id="CD010239-fig-0065" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 18 Duration of supplemental oxygen administration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 19 Mortality to follow up (&gt; 18 months)." data-id="CD010239-fig-0066" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 19 Mortality to follow up (&gt; 18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge)." data-id="CD010239-fig-0067" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 21 Duration of hospitalisation (days)." data-id="CD010239-fig-0068" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 21 Duration of hospitalisation (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-003-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-003-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 22 Patent ductus arteriosus (not prespecified)." data-id="CD010239-fig-0069" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues, Outcome 22 Patent ductus arteriosus (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-003-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 1 Mortality near term corrected age or discharge (latest reported)." data-id="CD010239-fig-0070" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 1 Mortality near term corrected age or discharge (latest reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 2 Neurodevelopmental disability." data-id="CD010239-fig-0071" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 2 Neurodevelopmental disability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 3 IPPV in the delivery room." data-id="CD010239-fig-0072" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 3 IPPV in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 4 Intubation in the delivery room." data-id="CD010239-fig-0073" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 4 Intubation in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 5 Time to reach desired oxygen saturation target." data-id="CD010239-fig-0074" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 5 Time to reach desired oxygen saturation target. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 6 Retinopathy of prematurity." data-id="CD010239-fig-0075" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 6 Retinopathy of prematurity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 7 Severe retinopathy of prematurity (≥ stage 3)." data-id="CD010239-fig-0076" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 7 Severe retinopathy of prematurity (≥ stage 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 8 Intraventricular haemorrhage." data-id="CD010239-fig-0077" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 8 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 9 Severe intraventricular haemorrhage (grade 3 or 4)." data-id="CD010239-fig-0078" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 9 Severe intraventricular haemorrhage (grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 10 Periventricular leukomalacia." data-id="CD010239-fig-0079" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 10 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 11 Necrotising enterocolitis." data-id="CD010239-fig-0080" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 11 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 12 Chronic lung disease (28 days age)." data-id="CD010239-fig-0081" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 12 Chronic lung disease (28 days age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 13 Chronic lung disease (36 weeks' corrected age)." data-id="CD010239-fig-0082" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 13 Chronic lung disease (36 weeks' corrected age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth)." data-id="CD010239-fig-0083" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 15 Duration of respiratory support (mechanical ventilation) (days from birth)." data-id="CD010239-fig-0084" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 15 Duration of respiratory support (mechanical ventilation) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 16 Duration of respiratory support (CPAP) (days from birth)." data-id="CD010239-fig-0085" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 16 Duration of respiratory support (CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 17 Duration of supplemental oxygen administration." data-id="CD010239-fig-0086" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 17 Duration of supplemental oxygen administration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 18 Mortality to follow up (&gt; 18 months)." data-id="CD010239-fig-0087" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 18 Mortality to follow up (&gt; 18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 19 Duration of hospitalisation (days)." data-id="CD010239-fig-0088" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 19 Duration of hospitalisation (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-004-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-004-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes, Outcome 20 Patent ductus arteriosus (not prespecified)." data-id="CD010239-fig-0089" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.20</div> <div class="figure-caption"> <p>Comparison 4 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by highest SpO<sub>2</sub> limit at 10 minutes, Outcome 20 Patent ductus arteriosus (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-004-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 1 Mortality near term corrected age or discharge (latest reported)." data-id="CD010239-fig-0090" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 1 Mortality near term corrected age or discharge (latest reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 2 Neurodevelopmental disability." data-id="CD010239-fig-0091" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 2 Neurodevelopmental disability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 3 IPPV in the delivery room." data-id="CD010239-fig-0092" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 3 IPPV in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 4 Intubation in the delivery room." data-id="CD010239-fig-0093" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 4 Intubation in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 5 Time to reach desired oxygen saturation target." data-id="CD010239-fig-0094" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 5 Time to reach desired oxygen saturation target. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 6 Time to reach heart rate &gt; 100 bpm." data-id="CD010239-fig-0095" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 6 Time to reach heart rate &gt; 100 bpm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 7 Retinopathy of prematurity." data-id="CD010239-fig-0096" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 7 Retinopathy of prematurity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 8 Severe retinopathy of prematurity (≥ stage 3)." data-id="CD010239-fig-0097" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 8 Severe retinopathy of prematurity (≥ stage 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 9 Intraventricular haemorrhage." data-id="CD010239-fig-0098" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 9 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4)." data-id="CD010239-fig-0099" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 11 Periventricular leukomalacia." data-id="CD010239-fig-0100" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 11 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 12 Necrotising enterocolitis." data-id="CD010239-fig-0101" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 12 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 13 Chronic lung disease (28 days age)." data-id="CD010239-fig-0102" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 13 Chronic lung disease (28 days age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 14 Chronic lung disease (36 weeks' corrected age)." data-id="CD010239-fig-0103" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 14 Chronic lung disease (36 weeks' corrected age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth)." data-id="CD010239-fig-0104" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth)." data-id="CD010239-fig-0105" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.16</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 16 Duration of respiratory support (mechanical ventilation) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 17 Duration of respiratory support (CPAP) (days from birth)." data-id="CD010239-fig-0106" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.17</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 17 Duration of respiratory support (CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 18 Duration of supplemental oxygen administration." data-id="CD010239-fig-0107" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.18</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 18 Duration of supplemental oxygen administration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 19 Mortality to follow up (&gt; 18 months)." data-id="CD010239-fig-0108" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.19</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 19 Mortality to follow up (&gt; 18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge)." data-id="CD010239-fig-0109" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.20</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 20 Postnatal growth failure (weight &lt; 10th percentile at discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 21 Duration of hospitalisation (days)." data-id="CD010239-fig-0110" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.21</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 21 Duration of hospitalisation (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-005-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-005-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 22 Patent ductus arteriosus (not prespecified)." data-id="CD010239-fig-0111" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.22</div> <div class="figure-caption"> <p>Comparison 5 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration subgrouped by gestational age, Outcome 22 Patent ductus arteriosus (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-005-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 1 Mortality near term corrected age or discharge (latest reported)." data-id="CD010239-fig-0112" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 1 Mortality near term corrected age or discharge (latest reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 2 Neurodevelopmental disability." data-id="CD010239-fig-0113" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 2 Neurodevelopmental disability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 3 IPPV in the delivery room." data-id="CD010239-fig-0114" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 3 IPPV in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 4 Intubation in the delivery room." data-id="CD010239-fig-0115" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 4 Intubation in the delivery room. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 5 Time to reach desired oxygen saturation target." data-id="CD010239-fig-0116" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 5 Time to reach desired oxygen saturation target. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified)." data-id="CD010239-fig-0117" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 6 Time to reach heart rate &gt; 100 bpm (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 7 Retinopathy of prematurity." data-id="CD010239-fig-0118" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 7 Retinopathy of prematurity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 8 Severe retinopathy of prematurity (≥ stage 3)." data-id="CD010239-fig-0119" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 8 Severe retinopathy of prematurity (≥ stage 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 9 Intraventricular haemorrhage." data-id="CD010239-fig-0120" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 9 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4)." data-id="CD010239-fig-0121" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 10 Severe intraventricular haemorrhage (grade 3 or 4). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 11 Necrotising enterocolitis." data-id="CD010239-fig-0122" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 11 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 12 Chronic lung disease (28 days age)." data-id="CD010239-fig-0123" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 12 Chronic lung disease (28 days age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 13 Chronic lung disease (36 weeks' corrected age)." data-id="CD010239-fig-0124" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 13 Chronic lung disease (36 weeks' corrected age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth)." data-id="CD010239-fig-0125" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 15 Duration of respiratory support (mechanical ventilation) (days from birth)." data-id="CD010239-fig-0126" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.15</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 15 Duration of respiratory support (mechanical ventilation) (days from birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 16 Duration of supplemental oxygen administration." data-id="CD010239-fig-0127" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.16</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 16 Duration of supplemental oxygen administration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 17 Mortality to follow up (&gt; 18 months)." data-id="CD010239-fig-0128" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.17</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 17 Mortality to follow up (&gt; 18 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 18 Postnatal growth failure (weight &lt; 10th percentile at discharge)." data-id="CD010239-fig-0129" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.18</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 18 Postnatal growth failure (weight &lt; 10th percentile at discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 19 Duration of hospitalisation (days)." data-id="CD010239-fig-0130" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.19</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 19 Duration of hospitalisation (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010239-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/urn:x-wiley:14651858:media:CD010239:CD010239-CMP-006-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_t/tCD010239-CMP-006-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 20 Patent ductus arteriosus (not prespecified)." data-id="CD010239-fig-0131" src="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.20</div> <div class="figure-caption"> <p>Comparison 6 Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration ‐ sensitivity analysis, Outcome 20 Patent ductus arteriosus (not prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/media/CDSR/CD010239/image_n/nCD010239-CMP-006-20.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010239-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentrations titrated to oxygen saturations during resuscitation of preterm infants at birth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants<br/> <b>Settings:</b> at birth<br/> <b>Intervention:</b> lower oxygen concentrations (FiO<sub>2</sub> &lt; 0.4) titrated to oxygen saturations during resuscitation<br/> <b>Comparison:</b> higher oxygen concentrations (FiO<sub>2</sub> ≥ 0.4) titrated to oxygen saturations during resuscitation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Lower (FiO<sub>2</sub> &lt; 0.4) versus higher (FiO<sub>2</sub> ≥ 0.4) oxygen concentration</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality, near term corrected age or discharge</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.05</b> <br/> (0.68 to 1.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>914<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>single study targeting lowest SpO<sub>2</sub> &lt; 85% reported increased mortality for infants resuscitated with air compared to 100% oxygen (<a href="./references#CD010239-bbs2-0006" title="OeiJ , LuiK , WrightIM , CravenP , SaugstadOD , SmythJP , et al. Targeted oxygen in the resuscitation of preterm infants and their developmental outcomes (TO2RPIDO): A randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015;51:34. OeiJL , SaugstadOD , LuiK , WrightIM , SmythJP , CravenP , et al. Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics2017;139(1):e20161452. [DOI: 10.1542/peds.2016‐1452; 28034908] PerroneS , TatarannoML , NegroS , LonginiM , MarzocchiB , ProiettiF , et al. Early identification of the risk for free radicals related diseases in preterm newborns. Pediatric Academic Societies' Abstract Archive 2002‐2015. 2010. [E‐PAS20103748.557] TatarannoML , OeiJL , PerroneS , WrightIM , SmythJP , LuiK , et al. Resuscitating preterm infants with 100% oxygen is associated with higher oxidative stress than room air. Acta Paediatrica2015;104(8):759‐65. [DOI: 10.1111/apa.13039; PUBMED: 25966608] ">Oei 2016</a>). </p> <p>Meta‐analysis of 9 studies (627 infants) targeting lowest SpO<sub>2</sub> 85% to 90% found no difference in mortality. </p> <p>No subgroup differences according to inspired oxygen concentration strata, highest SpO<sub>2</sub> limit, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>76 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 1000</b><br/> (52 to 124) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b><br/> (46 to 111) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Neurodevelopmental disability</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.82</b> <br/> (0.49 to 1.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>208<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>both studies compared FiO<sub>2</sub> ≥ 0.3 to &lt; 0.4 versus FiO<sub>2</sub> ≥ 0.6 to 1.0 and had a lowest SpO<sub>2</sub> target 85 to 90%. </p> <p>Quality of evidence downgraded due to inconsistency and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>199 per 1000</b><br/> (119 to 327) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>170 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>139 per 1000</b><br/> (83 to 230) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Intubation in the delivery room</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.98</b> <br/> (0.82 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>875<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>352 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>345 per 1000</b><br/> (289 to 416) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>386 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>378 per 1000</b><br/> (317 to 455) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Severe retinopathy of prematurity (≥ stage 3)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.57</b> <br/> (0.24 to 1.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>453<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>58 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b><br/> (14 to 79) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b><br/> (17 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Severe intraventricular haemorrhage (grade 3 or 4)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.93</b> <br/> (0.51 to 1.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>596<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b><br/> (32 to 108) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>73 per 1000</b><br/> (40 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.98</b> <br/> (0.51 to 1.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>807<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b><br/> (24 to 88) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b><br/> (21 to 77) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Chronic lung disease (36 weeks' corrected age)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.91</b> <br/> (0.72 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>862<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subgroup analyses:</p> <p>no subgroup differences according to inspired oxygen concentration strata, lowest or highest SpO<sub>2</sub> target, or gestational age. </p> <p>Quality of evidence downgraded due to risk of bias, inconsistency and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>269 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>244 per 1000</b><br/> (193 to 306) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>228 per 1000</b><br/> (180 to 285) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>FiO<sub>2</sub>:</b> fractional inspired oxygen;<b>SpO<sub>2</sub>:</b> oxygen saturation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Two studies at low risk of bias.<br/> <sup>2</sup> Wide confidence intervals. <br/> <sup>3</sup> Moderate heterogeneity. <br/> <sup>4</sup> A single study at low risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/full#CD010239-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010239-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>914</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.68, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurodevelopmental disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 IPPV in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.83, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intubation in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>875</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.82, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to reach desired oxygen saturation target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.83, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Time to reach heart rate &gt; 100 bpm (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.43, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe retinopathy of prematurity (≥ stage 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.46, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe intraventricular haemorrhage (grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.51, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.09, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.51, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Chronic lung disease (28 days' age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.41, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Chronic lung disease (36 weeks' corrected age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.72, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.39 [‐13.49, ‐11.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Duration of respiratory support (mechanical ventilation) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [‐1.33, 2.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Duration of respiratory support (CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐5.39, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Duration of supplemental oxygen administration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.23 [6.52, 11.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mortality to follow up (&gt; 18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>540</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.59, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Postnatal growth failure (weight &lt; 10th percentile at discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐12.22, 8.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Patent ductus arteriosus (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>766</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.77, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010239-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Lower versus higher oxygen concentration subgrouped by FiO2 </span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality near term corrected age or discharge (latest reported) subgrouped by inspired oxygen concentration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.09, 14.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.84, 3.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.42, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurodevelopmental disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 IPPV in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.7 [0.28, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.77, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.84, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intubation in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.16, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.81, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to reach desired oxygen saturation target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.83, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Time to reach heart rate &gt; 100 bpm (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.43, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe retinopathy of prematurity (≥ stage 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.15, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [0.19, 77.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 2.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.47, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe intraventricular haemorrhage (grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.27, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.49, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.08, 18.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.07, 4.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.31, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.52, 3.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Chronic lung disease (28 days age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.53, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Chronic lung disease (36 weeks' corrected age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 FiO2 0.21 versus FiO2 ≥ 0.4 to &lt; 0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.05, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>492</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.72, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.70 [‐14.85, ‐12.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐2.63, 4.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Duration of respiratory support (mechanical ventilation) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐4.16, 3.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [‐1.38, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Duration of respiratory support (CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.79 [‐5.84, 2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐11.00, 10.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Duration of supplemental oxygen administration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.4 [9.25, 15.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐5.37, 5.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mortality to follow up (&gt; 18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.92, 5.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.28, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Postnatal growth failure (weight &lt; 10th percentile at discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.35 [‐15.26, 6.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.0 [‐8.96, 64.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Patent ductus arteriosus (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>766</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.77, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 FiO2 0.21 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.57, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 FiO2 ≥ 0.3 to &lt; 0.4 versus FiO2 ≥ 0.6 to 1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.82, 1.29]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Lower versus higher oxygen concentration subgrouped by FiO2 </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010239-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality near term corrected age or discharge (latest reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>914</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.68, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.78 [1.03, 7.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.46, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurodevelopmental disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 IPPV in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.83, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.83, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intubation in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>875</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.82, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.73, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>588</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.78, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to reach desired oxygen saturation target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.83, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.83, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Time to reach heart rate &gt; 100 bpm (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.43, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.43, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe retinopathy of prematurity (≥ stage 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.15, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.19, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.46, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.46, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe intraventricular haemorrhage (grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.51, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.61, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.09, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.09, 4.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.51, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.97 [0.59, 41.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.36, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Chronic lung disease (28 days' age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.41, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.41, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Chronic lung disease (36 weeks' corrected age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.64, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.57, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.58, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.39 [‐13.49, ‐11.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.70 [‐14.85, ‐12.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐2.63, 4.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Duration of respiratory support (mechanical ventilation) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [‐1.15, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [‐1.15, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Duration of respiratory support (CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐5.62, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐5.62, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Duration of supplemental oxygen administration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.67 [6.96, 12.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.4 [9.25, 15.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [‐3.64, 7.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mortality to follow up (&gt; 18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>540</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.59, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.92, 5.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.28, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Postnatal growth failure (weight &lt; 10th percentile at discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐12.22, 8.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐12.22, 8.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Patent ductus arteriosus (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>766</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.79, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 SpO2 target &lt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.59, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.79, 1.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by lower limit of oxygen saturation range at 5 to 10 mintues</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010239-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality near term corrected age or discharge (latest reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.72, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.41, 6.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.67, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurodevelopmental disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.42, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.42, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 IPPV in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.60, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.76, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intubation in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.78, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.49, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.77, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to reach desired oxygen saturation target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐3.28, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐3.28, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.36, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.06, 6.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.36, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Severe retinopathy of prematurity (≥ stage 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.16, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.16, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.30, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.30, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Severe intraventricular haemorrhage (grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.30, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.12, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.27, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.09, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.08, 18.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>669</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.39, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.02, 9.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.40, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Chronic lung disease (28 days age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Chronic lung disease (36 weeks' corrected age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>734</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.73, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.20, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>692</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.74, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.70 [‐14.85, ‐12.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.70 [‐14.85, ‐12.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Duration of respiratory support (mechanical ventilation) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [‐1.02, 2.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.75 [‐37.24, 27.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [‐1.01, 2.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Duration of respiratory support (CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.11 [‐7.08, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.0 [‐9.18, 33.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Higher SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.66 [‐7.71, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Duration of supplemental oxygen administration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.87 [7.12, 12.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.25 [‐50.97, 30.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.96 [7.21, 12.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Mortality to follow up (&gt; 18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.65, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.65, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.35 [‐15.26, 6.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.35 [‐15.26, 6.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Patent ductus arteriosus (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.75, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 SpO2 target 85 to 90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.60, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 SpO2 target 91 to 95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.72, 1.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by highest SpO2 limit at 10 minutes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010239-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality near term corrected age or discharge (latest reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>832</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.66, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.68, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurodevelopmental disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.64 [0.42, 31.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.64 [0.42, 31.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 IPPV in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.84, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.84, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intubation in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.85, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.84, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.49, 2.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to reach desired oxygen saturation target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.83, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.83, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Time to reach heart rate &gt; 100 bpm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.38, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.38, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe retinopathy of prematurity (≥ stage 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.46, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.43, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.26 [0.09, 54.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.52, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.52, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe intraventricular haemorrhage (grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.55, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.51, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.27 [0.15, 72.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.08, 18.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.08, 18.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.78, 3.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>483</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.80, 4.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.23, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Chronic lung disease (28 days age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.53, 3.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.53, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Chronic lung disease (36 weeks' corrected age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.36, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐2.63, 4.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐2.63, 4.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Duration of respiratory support (mechanical ventilation) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.64 [‐32.62, 5.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.64 [‐32.62, 5.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Duration of respiratory support (CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.09 [‐12.85, 8.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.09 [‐12.85, 8.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Duration of supplemental oxygen administration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐16.90, 15.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐16.90, 15.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mortality to follow up (&gt; 18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.20, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.20, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Postnatal growth failure (weight &lt; 10th percentile at discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.0 [‐8.96, 64.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.0 [‐8.96, 64.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Patent ductus arteriosus (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>710</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.81, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Gestation ≤ 28 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>483</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Gestation &gt; 28 to 32 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.54, 2.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration subgrouped by gestational age</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010239-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality near term corrected age or discharge (latest reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.25, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neurodevelopmental disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 IPPV in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.94, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intubation in the delivery room <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.79, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to reach desired oxygen saturation target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [‐0.26, 4.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Time to reach heart rate &gt; 100 bpm (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐1.21, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.39, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe retinopathy of prematurity (≥ stage 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [0.19, 77.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.47, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe intraventricular haemorrhage (grade 3 or 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.17, 3.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.46, 5.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Chronic lung disease (28 days age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.53, 3.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Chronic lung disease (36 weeks' corrected age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.90, 2.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Duration of respiratory support (mechanical ventilation or CPAP) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐2.63, 4.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Duration of respiratory support (mechanical ventilation) (days from birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [‐0.97, 3.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Duration of supplemental oxygen administration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.72 [‐2.78, 8.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Mortality to follow up (&gt; 18 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.28, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Postnatal growth failure (weight &lt; 10th percentile at discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>28.0 [‐8.96, 64.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Patent ductus arteriosus (not prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.88, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Lower (FiO2 &lt; 0.4) versus higher (FiO2 ≥ 0.4) oxygen concentration ‐ sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010239.pub2/references#CD010239-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010239.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010239-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010239-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010239-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD010239-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010239-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010239\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010239\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010239\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010239\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010239\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010239.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010239.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010239.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010239.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010239.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716068471"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010239.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716068475"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010239.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d967c698df409',t:'MTc0MDcxNjA2OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 